Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.1130678073642815e-19,7.9811507936507935,343.1972732369446,"['RPL5', 'RPL30', 'RPL10', 'RPL34', 'RPLP1', 'RPLP0', 'RPL11', 'RPL10A', 'RPL9', 'RPL6', 'RPS4X', 'RPL7A', 'RPS14', 'RPS17', 'RPS15A', 'RPL18A', 'RPS19', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL39', 'RPL17', 'RPS13', 'RPL41', 'RPS7', 'RPL21', 'RPS8', 'RPL35A', 'RPSA', 'RPS3A', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL24', 'FAU', 'RPL29', 'RPL28', 'UBA52', 'RPS21', 'RPS23']",1.0840037851778764e-16,0,0,45
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.464421721383504e-09,4.297300402067777,85.17811764302056,"['NDUFB7', 'UQCRB', 'NDUFA12', 'NDUFB5', 'ATP5MC2', 'NDUFB2', 'COX7A2', 'UQCR10', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'ATP5F1A', 'COX11', 'UQCRFS1', 'NDUFV3', 'NDUFV1', 'ATP5MF', 'NDUFA9', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'COX6B1', 'NDUFS5', 'SLC25A5']",6.321241715348688e-07,0,0,32
3,Oxidative phosphorylation WP623,2.6278365810886213e-08,5.5824258059434015,97.43856192387051,"['NDUFA9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFA5', 'NDUFB5', 'ATP5PB', 'NDUFA4', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'NDUFS5', 'NDUFV3', 'NDUFV1', 'ATP5MF']",4.493600553661542e-06,0,0,22
4,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,5.577705324405532e-06,10.458633822218621,126.51530192060403,"['EIF5', 'EIF2S3', 'EIF1AX', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF3D', 'EIF3A', 'EIF1']",0.0007153407078550094,0,0,10
5,Mitochondrial complex I assembly model OXPHOS system WP4324,1.0786793200304692e-05,4.128846153846154,47.22238978350591,"['NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'ACAD9', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS5', 'TMEM126B', 'NDUFV3', 'NDUFV1']",0.0011067249823512612,0,0,18
6,Nonalcoholic fatty liver disease WP4396,1.825826807422874e-05,2.5322916666666666,27.6295622432042,"['NDUFA13', 'NDUFB7', 'UQCRB', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'PRKAG1', 'NDUFB2', 'COX7A2', 'UQCR10', 'COX7C', 'CDC42', 'AKT3', 'UQCRFS1', 'NDUFV3', 'RAC1', 'NDUFV1', 'NDUFA9', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'TRAF2', 'NDUFC1', 'NFKB1', 'COX6B1', 'ERN1', 'DDIT3', 'NDUFS5', 'BAX']",0.0015610819203465572,0,0,33
7,Translation Factors WP107,5.899731125554106e-05,3.6674259681093395,35.7134626107734,"['EIF1AX', 'EIF2AK2', 'EIF2S2', 'EIF1', 'EEF1G', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF3F', 'EIF3D', 'EIF4G3', 'EIF4B', 'EIF3A', 'EIF4G1']",0.0043236600962989384,0,0,17
8,mRNA Processing WP411,7.222714381379044e-05,2.401287086833041,22.89794037808623,"['SF3B5', 'SF3B3', 'DHX8', 'RNMT', 'CSTF2T', 'HNRNPR', 'SNU13', 'YBX1', 'SNRPD1', 'SNRPB2', 'SNRPD3', 'TXNL4A', 'HNRNPA1', 'SF3B1', 'SF3A1', 'PRMT2', 'NCBP2', 'SUPT5H', 'LSM2', 'PRPF4', 'HNRNPM', 'LSM7', 'PHF5A', 'SNRPG', 'CD2BP2', 'SNRPE', 'SNRPF', 'DNAJC8', 'RBMX', 'SNRPB', 'SRSF9']",0.0046315655970593115,0,0,31
9,Mitochondrial CIV Assembly WP4922,0.00020360005442236775,4.393185689948893,37.339235999728444,"['TMEM177', 'COA3', 'COX16', 'PET100', 'NDUFA4', 'SCO2', 'COX11', 'COX7A2', 'COX14', 'COX7C', 'PET117', 'COX6B1']",0.011605203102074961,0,0,12
10,Photodynamic therapy-induced unfolded protein response WP3613,0.0002526335947265244,5.2264808362369335,43.29392174812233,"['NARS', 'ERN1', 'XBP1', 'WARS', 'HSPA5', 'DDIT3', 'DNAJB11', 'CALR', 'PDIA6', 'HSP90B1']",0.012960103409470703,0,0,10
11,Proteasome Degradation WP183,0.00250888111528142,2.6149845603770516,15.658314154410943,"['UBE2B', 'PSMD13', 'HLA-A', 'HLA-F', 'PSMA7', 'PSMD8', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMA1', 'PSMB3', 'PSME3', 'PSMC1', 'UBC', 'PSME2']",0.1109175445094557,0,0,15
12,Cellular Proteostasis WP4918,0.0025945624446656306,14.59807801017524,86.92188173788539,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4']",0.1109175445094557,0,0,4
13,16p11.2 proximal deletion syndrome WP4949,0.005234530200311267,2.2967848493979264,12.063812307334228,"['CCT3', 'CCT2', 'TRAF2', 'KIF22', 'SEZ6L2', 'NFKB1', 'CCT6A', 'PPP4R1', 'HIRIP3', 'PPP4R4', 'PPARG', 'ALDOA', 'CCT7', 'CDIPT', 'CCT5', 'CCT4']",0.2065626148276677,0,0,16
14,Mitochondrial complex III assembly WP4921,0.005829715223384936,4.868892661761932,25.049416286901014,"['UQCRB', 'UQCC3', 'UQCC2', 'LYRM7', 'UQCRFS1', 'UQCR10']",0.20922996643971833,0,0,6
15,Ciliary landscape WP4352,0.0061178352760151555,1.6468125960061444,8.393057726733483,"['ECHS1', 'PSMD13', 'VPS4A', 'COPS7A', 'EHBP1', 'RPGR', 'PSMD8', 'EXOSC7', 'PSMD7', 'PGRMC2', 'RMND5A', 'EXOSC9', 'BBS9', 'SNRPB2', 'RAC1', 'DCAF11', 'BBS4', 'RAB2A', 'NDUFA9', 'DYNLT1', 'NDUFA5', 'LCA5', 'NFKB1', 'AIMP1', 'COPS4', 'MKLN1', 'COPS6', 'MSH2', 'TBC1D4', 'RAB14', 'MFAP1', 'TIPRL', 'CD2BP2', 'MCM4', 'MCM6', 'CALM1', 'COPS8']",0.20922996643971833,0,0,37
16,p38 MAPK Signaling Pathway WP400,0.013829449146097609,2.740221088435374,11.730763072256567,"['CDC42', 'STAT1', 'TRADD', 'DDIT3', 'TRAF2', 'GRB2', 'RAC1', 'MEF2D', 'HMGN1']",0.44340671324675457,0,0,9
17,Methionine De Novo and Salvage Pathway WP3580,0.01573668462373797,3.650820599886814,15.157333460136346,"['AHCY', 'ADI1', 'ODC1', 'SMS', 'TXN', 'SRM']",0.47487760070456336,0,0,6
18,Selenium Micronutrient Network WP15,0.018976246054589634,2.193185689948893,8.695032246456947,"['SELENOM', 'GPX4', 'TXNRD2', 'SELENOW', 'PNPO', 'TXN', 'SELENOK', 'SEPHS2', 'NFKB1', 'SELENOH', 'SOD1', 'MSRB1']",0.5408230125558046,0,0,12
19,VEGFA-VEGFR2 Signaling Pathway WP3888,0.022545740475415018,1.3590914577716975,5.153959025586298,"['RPL5', 'FLT1', 'LDB2', 'RPL10A', 'ACTG1', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'ELOC', 'RAC1', 'ATP6V1E1', 'ACP1', 'PRKG1', 'HSP90AA1', 'SSR4', 'TPM3', 'SSR3', 'GAB1', 'SHROOM2', 'SARS', 'PDIA6', 'SND1', 'ERN1', 'RCN1', 'FSCN1', 'PRKD1', 'TKT', 'ALDOA', 'PTMA', 'ENG', 'SET', 'EPB41', 'PXN', 'TXN', 'CAMKK2', 'CDC42', 'STIP1', 'DHX36', 'ASCC3', 'CCT7', 'TXNDC5', 'EGR1', 'SDF2L1', 'STAT1', 'IDH2', 'NFKB1', 'DNAJA1', 'AFDN', 'BMP2', 'HYOU1', 'TPP1', 'GRB2', 'EIF3F', 'CALR', 'GRSF1', 'EIF3D', 'EIF4G2', 'EIF4G1']",0.6087349928362055,0,0,59
20,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.029262865317120388,2.2140291170353565,7.81870204504388,"['ERN1', 'PPP1R2', 'XBP1', 'MAP1LC3A', 'HSPA5', 'PPP1R7', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'EIF2AK2']",0.7122002427577894,0,0,10
21,p53 transcriptional gene network WP4963,0.033517050103832303,2.060959282866207,6.998401521083335,"['MSH2', 'SIVA1', 'XRCC5', 'MGMT', 'GADD45A', 'SESN1', 'SESN2', 'ULK2', 'BAX', 'FANCC', 'ISG15']",0.7122002427577894,0,0,11
22,Cysteine and methionine catabolism WP4504,0.03472445591559253,4.169264313978842,14.010024981498178,"['AHCY', 'ETHE1', 'SUOX', 'CDO1']",0.7122002427577894,0,0,4
23,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.03472445591559253,4.169264313978842,14.010024981498178,"['GALNT3', 'CCND1', 'NFKB1', 'FGFR2']",0.7122002427577894,0,0,4
24,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.03472445591559253,4.169264313978842,14.010024981498178,"['SFRP1', 'CCND1', 'NRG3', 'ERBB4']",0.7122002427577894,0,0,4
25,Melanoma WP4685,0.035750166446486764,1.9003636363636363,6.3304920181969075,"['GADD45A', 'MITF', 'BRAF', 'FOS', 'CDK6', 'CCND1', 'ERBB4', 'AKT3', 'BAX', 'CALM3', 'GRB2', 'RAC1', 'CALM1']",0.7122002427577894,0,0,13
26,7q11.23 copy number variation syndrome WP4932,0.03609591873626223,1.7267305745380916,5.735465927336911,"['ATP5PB', 'ATP5MC2', 'VPS37C', 'DDX21', 'UBE2L6', 'FBLN5', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'DNAJC30', 'NUP62', 'EIF4H', 'GRB2', 'SQSTM1', 'SF3B1', 'PRKG1', 'FBN1']",0.7122002427577894,0,0,17
27,Gastric acid production WP2596,0.04018406058058807,14.582721626199888,46.873021412956405,"['CCK', 'VIP']",0.72253699872708,0,0,2
28,let-7 inhibition of ES cell reprogramming WP3299,0.04018406058058807,14.582721626199888,46.873021412956405,"['SOX2', 'EGR1']",0.72253699872708,0,0,2
29,"Cerebral organic acidurias, including diseases WP4519",0.04225362565655438,5.470338983050848,17.308508740785093,"['GCDH', 'MDH2', 'IDH2']",0.72253699872708,0,0,3
30,Pentose Phosphate Metabolism WP134,0.04225362565655438,5.470338983050848,17.308508740785093,"['TALDO1', 'PGLS', 'TKT']",0.72253699872708,0,0,3
31,The influence of laminopathies on Wnt signaling WP4844,0.044567388096876166,2.4335598338995847,7.570203300916089,"['WNT10B', 'CDK6', 'CCND1', 'FNTA', 'PPARG', 'EMD', 'RUNX2']",0.7375183901192732,0,0,7
32,Heme Biosynthesis WP561,0.0616597933292872,4.375932203389831,12.19188626985145,"['ALAD', 'FECH', 'UROS']",0.9585295144825555,0,0,3
33,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.0616597933292872,4.375932203389831,12.19188626985145,"['CAMK2D', 'CCND2', 'MEF2D']",0.9585295144825555,0,0,3
34,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.06492434338883926,1.7531856899488927,4.794143484141656,"['PSMD8', 'HSPA9', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'HSPA5', 'PSMD13', 'PSMC1', 'UBE2L6', 'UBE2G2', 'HSPA14']",0.9795937693668982,0,0,12
35,Immune response to tuberculosis WP4197,0.06987363140138562,2.6058500323206206,6.934341356187919,"['STAT1', 'TAP1', 'IFIT3', 'PTPN2', 'IFNAR1']",0.9893137093947314,0,0,5
36,Proximal tubule transport WP4917,0.07040558488515575,2.013871251343167,5.343772501722109,"['ATP6V1A', 'ATP6V1G1', 'FXYD2', 'SLC1A1', 'SLC3A2', 'ATP6V1E1', 'ATP6V1C1', 'ATP6V1F']",0.9893137093947314,0,0,8
37,Oxidative Stress WP408,0.07239874713901857,2.3045304262353676,6.050697388612499,"['NFIX', 'TXNRD2', 'FOS', 'NFKB1', 'TXN2', 'SOD1']",0.9893137093947314,0,0,6
38,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.07397696738080249,7.290796160361378,18.985244034519955,"['SLIT2', 'RAC1']",0.9893137093947314,0,0,2
39,Cytosolic DNA-sensing pathway WP4655,0.07658905045728262,1.8774052478134111,4.823619475130225,"['POLR3A', 'POLR3GL', 'TRADD', 'POLR2E', 'POLR2F', 'ADAR', 'ISG15', 'NFKB1', 'NFKBIB']",0.9893137093947314,0,0,9
40,RANKL/RANK signaling pathway WP2018,0.0859729825750837,1.8251133786848073,4.478321193240734,"['CDC42', 'STAT1', 'TRAF2', 'MITF', 'TAB2', 'RAC1', 'FOS', 'SQSTM1', 'NFKB1']",0.9893137093947314,0,0,9
41,Exercise-induced Circadian Regulation WP410,0.09601090320826354,1.7756480970766686,4.1608646776867175,"['DNAJA1', 'BTG1', 'SUMO1', 'STBD1', 'CRY2', 'CRY1', 'TAB2', 'ERC2', 'EIF4G2']",0.9893137093947314,0,0,9
42,TNF-alpha signaling pathway WP231,0.09716445593467163,1.5493651696039417,3.612112974776597,"['HSP90AA1', 'CSNK2A1', 'TRADD', 'TRAF2', 'TXN', 'CFLAR', 'NFKB1', 'MADD', 'BAX', 'GRB2', 'TAB2', 'RAC1', 'SKP1', 'NFKBIB']",0.9893137093947314,0,0,14
43,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.09743053351931547,2.652345958168457,6.176294258696222,"['CCND1', 'CFLAR', 'NFKB1', 'BCL2L2']",0.9893137093947314,0,0,4
44,Genotoxicity pathway WP4286,0.1066980563098175,1.7287862513426424,3.868595474535882,"['COIL', 'RPS27', 'GADD45A', 'EI24', 'SEL1L', 'PCDH8', 'RAPGEF2', 'CBLB', 'TM7SF3']",0.9893137093947314,0,0,9
45,DNA damage response WP707,0.10981730024943603,1.659103800340329,3.6648561046399424,"['CDKN1B', 'MRE11', 'CCND2', 'CDK6', 'CCND1', 'GADD45A', 'SESN1', 'RAD17', 'BAX', 'ATRIP']",0.9893137093947314,0,0,10
46,EV release from cardiac cells and their functional effects WP3297,0.11359959731311216,4.860154338415208,10.57120174063177,"['ERBB4', 'RGS16']",0.9893137093947314,0,0,2
47,Metastatic brain tumor WP2249,0.11359959731311216,4.860154338415208,10.57120174063177,"['CDC42', 'CDK6']",0.9893137093947314,0,0,2
48,Mitochondrial fatty acid synthesis pathway WP4317,0.11359959731311216,4.860154338415208,10.57120174063177,"['MECR', 'HSD17B12']",0.9893137093947314,0,0,2
49,The alternative pathway of fetal androgen synthesis WP4524,0.11359959731311216,4.860154338415208,10.57120174063177,"['STAR', 'HSD17B6']",0.9893137093947314,0,0,2
50,Myometrial relaxation and contraction pathways WP289,0.11442666316528059,1.3917909434167277,3.0171538540480367,"['RYR2', 'RGS17', 'CAMK2D', 'YWHAB', 'GSTO1', 'PDE4D', 'RGS16', 'LPAR1', 'FOS', 'NFKB1', 'ACTG1', 'GNG3', 'YWHAQ', 'GNG4', 'GNB1', 'CALM3', 'PRKD1', 'GNB5', 'ATF5', 'CALM1']",0.9893137093947314,0,0,20
51,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.11735067626092666,2.1454950758583977,4.596913277873279,"['TTC9', 'PNCK', 'CCND1', 'ERBB4', 'TPM3']",0.9893137093947314,0,0,5
52,Signal Transduction of S1P Receptor WP26,0.11735067626092666,2.1454950758583977,4.596913277873279,"['ASAH1', 'AKT3', 'MAPK6', 'PLCB1', 'GNAI2']",0.9893137093947314,0,0,5
53,Synaptic Vesicle Pathway WP2267,0.11802558704915449,1.6843275771847201,3.5991618488059527,"['DNM3', 'RAB3A', 'SLC32A1', 'SYT1', 'STXBP1', 'CLTA', 'AP2B1', 'CPLX2', 'CPLX3']",0.9893137093947314,0,0,9
54,Pregnane X receptor pathway WP2876,0.11806075356513414,2.431128697946109,5.194242427171186,"['NCOA1', 'HSP90AA1', 'PSMC5', 'DNAJC7']",0.9893137093947314,0,0,4
55,3q29 copy number variation syndrome WP4906,0.12050380218636979,1.6221087792273272,3.432502169317333,"['DYNC2H1', 'DYNLT1', 'NCBP2', 'CEP350', 'PXN', 'RNF8', 'PIGZ', 'MAD2L1BP', 'FBXO45', 'PIGX']",0.9893137093947314,0,0,10
56,Tumor suppressor activity of SMARCB1 WP4204,0.12908333394723143,1.9031519893703404,3.8963175174805658,"['CDK6', 'RBBP4', 'H3F3B', 'DPF2', 'ARID1B', 'GLI3']",0.9893137093947314,0,0,6
57,miRNA regulation of DNA damage response WP1530,0.13174160995667683,1.5867222372931515,3.216147573354995,"['CDKN1B', 'MRE11', 'CCND2', 'CDK6', 'CCND1', 'GADD45A', 'SESN1', 'RAD17', 'BAX', 'ATRIP']",0.9893137093947314,0,0,10
58,Pyrimidine metabolism WP4022,0.13203283980870248,1.4830433238636365,3.0027246411732116,"['DTYMK', 'POLR3GL', 'NME2', 'CTPS1', 'POLR3A', 'POLR2D', 'POLE3', 'POLR2E', 'POLR1E', 'TK2', 'POLR2G', 'UMPS', 'DCTPP1']",0.9893137093947314,0,0,13
59,Cell migration and invasion through p75NTR WP4561,0.13585510013438679,2.026143790849673,4.044520159738424,"['NTRK2', 'ARF1', 'AKT3', 'RAC1', 'EFNA5']",0.9893137093947314,0,0,5
60,RalA downstream regulated genes WP2290,0.13842499884312634,2.734322033898305,5.406921190144358,"['CDC42', 'RALBP1', 'RAC1']",0.9893137093947314,0,0,3
61,Constitutive Androstane Receptor Pathway WP2875,0.1403901976804472,2.243944862373353,4.405603384590453,"['SULT1A1', 'NCOA1', 'HSP90AA1', 'DNAJC7']",0.9893137093947314,0,0,4
62,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.15555447533974784,1.9193557989997618,3.5714591241759157,"['CCND2', 'CCND1', 'NFKB1', 'RUNX2', 'FGFR2']",0.9893137093947314,0,0,5
63,Peroxiredoxin 2 induced ovarian failure WP4873,0.1571536060058426,3.6448334274421232,6.7448793239068054,"['STAR', 'BAX']",0.9893137093947314,0,0,2
64,Pilocytic astrocytoma WP2253,0.1571536060058426,3.6448334274421232,6.7448793239068054,"['BRAF', 'GRB2']",0.9893137093947314,0,0,2
65,Fragile X Syndrome  WP4549,0.15810762349817323,1.341287284144427,2.473976653034459,"['CYFIP2', 'NTRK2', 'DUSP3', 'HOMER1', 'KCND2', 'GAB1', 'CLTA', 'BRAF', 'AKAP5', 'AP2B1', 'EEF1A1', 'ARC', 'GRM5', 'ALDH5A1', 'GRB2', 'PLCB1', 'EIF4G1', 'HCN1']",0.9893137093947314,0,0,18
66,BDNF-TrkB Signaling WP3676,0.1635307902906819,1.75062818336163,3.1699569619960264,"['NTRK2', 'ARC', 'HOMER1', 'GAB1', 'BRAF', 'GRB2']",0.9893137093947314,0,0,6
67,Nucleotide metabolism WP404,0.16423491288487815,2.083501574739562,3.7637570051519655,"['PRPS1', 'NME2', 'OAZ1', 'SRM']",0.9893137093947314,0,0,4
68,Purine metabolism and related disorders WP4224,0.16423491288487815,2.083501574739562,3.7637570051519655,"['PRPS1', 'GRM5', 'PFAS', 'ITPA']",0.9893137093947314,0,0,4
69,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.16882292759543369,2.4303201506591336,4.323308373677502,"['SFRP1', 'BMP2', 'SST']",0.9893137093947314,0,0,3
70,Cell Differentiation - Index expanded WP2023,0.16882292759543369,2.4303201506591336,4.323308373677502,"['SOX2', 'MEF2D', 'RUNX2']",0.9893137093947314,0,0,3
71,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.16882292759543369,2.4303201506591336,4.323308373677502,"['RYR2', 'CCK', 'PLCB1']",0.9893137093947314,0,0,3
72,Galanin receptor pathway WP4970,0.16882292759543369,2.4303201506591336,4.323308373677502,"['CDKN1B', 'PPARG', 'FOS']",0.9893137093947314,0,0,3
73,Hedgehog Signaling Pathway Netpath WP47,0.16882292759543369,2.4303201506591336,4.323308373677502,"['STK36', 'SAP18', 'GLI3']",0.9893137093947314,0,0,3
74,Overview of nanoparticle effects WP3287,0.16882292759543369,2.4303201506591336,4.323308373677502,"['COL4A1', 'AKT3', 'BAX']",0.9893137093947314,0,0,3
75,Copper homeostasis WP3286,0.1692451444909829,1.5774596125870914,2.8022103863317374,"['BACE1', 'CCS', 'CCND1', 'SCO2', 'COX11', 'MAPT', 'ATOX1', 'SOD1']",0.9893137093947314,0,0,8
76,Glycosylation and related congenital defects WP4521,0.17634341191660952,1.8232466063348416,3.1639199127536175,"['DPM2', 'DPM3', 'ALG14', 'MAGT1', 'ALG11']",0.9893137093947314,0,0,5
77,Ras signaling WP4223,0.1769255370614265,1.2751715572960576,2.208630711857754,"['NTRK2', 'RALBP1', 'RAB5C', 'FLT1', 'PLA2G4C', 'GAB1', 'RASAL2', 'NFKB1', 'CDC42', 'AFDN', 'GNG3', 'MRAS', 'GNG4', 'AKT3', 'GNB1', 'CALM3', 'GRB2', 'GNB5', 'RAC1', 'RGL1', 'CALM1', 'FGFR2']",0.9893137093947314,0,0,22
78,Androgen receptor signaling pathway WP138,0.18542766944915862,1.3750411725955205,2.317068672781628,"['NCOA1', 'DSTN', 'RNF4', 'RUNX2', 'CDC42', 'CCND1', 'SUMO1', 'RACK1', 'KAT7', 'RAC1', 'CALR', 'FKBP4', 'PLPP1']",0.9893137093947314,0,0,13
79,Pancreatic adenocarcinoma pathway WP4263,0.197193085909305,1.3552922077922078,2.2004143431528638,"['RALBP1', 'STAT1', 'GADD45A', 'PEBP1', 'BRAF', 'NFKB1', 'CDC42', 'CDK6', 'CCND1', 'AKT3', 'BAX', 'RAC1', 'ARHGEF6']",0.9893137093947314,0,0,13
80,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.20090077428080602,2.1871186440677968,3.510203279949929,"['CDK8', 'H2AFY', 'CCND1']",0.9893137093947314,0,0,3
81,miRNAs involved in DNA damage response WP1545,0.20090077428080602,2.1871186440677968,3.510203279949929,"['CDKN1B', 'CDK6', 'CCND1']",0.9893137093947314,0,0,3
82,NOTCH1 regulation of endothelial cell calcification WP3413,0.20090077428080602,2.1871186440677968,3.510203279949929,"['LPAR1', 'SOX6', 'DLL3']",0.9893137093947314,0,0,3
83,Disruption of postsynaptic signaling by CNV WP4875,0.2014075264718541,1.6207004967616172,2.5970508778571166,"['RYR2', 'CAMK2D', 'ARC', 'DLG2', 'HOMER1', 'DLGAP1']",0.9893137093947314,0,0,6
84,Dual hijack model of Vif in HIV infection WP3300,0.20311361207317466,2.9156408808582723,4.647501798629641,"['ELOB', 'ELOC']",0.9893137093947314,0,0,2
85,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.20311361207317466,2.9156408808582723,4.647501798629641,"['AHCY', 'CDO1']",0.9893137093947314,0,0,2
86,Sulfation Biotransformation Reaction WP692,0.20311361207317466,2.9156408808582723,4.647501798629641,"['SULT1A1', 'SULT4A1']",0.9893137093947314,0,0,2
87,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.20984013945513164,1.4029844234041624,2.190632896778737,"['EGR1', 'CDKN1B', 'STAT1', 'PDE4D', 'GNB1', 'BRAF', 'FOS', 'PLCB1', 'GNAI2', 'MYL12B']",0.9893137093947314,0,0,10
88,Striated Muscle Contraction Pathway WP383,0.2156752703679792,1.8227812323346524,2.7961124709994896,"['TPM4', 'TPM3', 'TPM1', 'ACTG1']",0.9893137093947314,0,0,4
89,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.2171816848070418,1.4588101983002832,2.227633834909739,"['ERN1', 'BEX3', 'CDKN1B', 'HSPA5', 'SERBP1', 'SQSTM1', 'TNFRSF21', 'NFKB1']",0.9893137093947314,0,0,8
90,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2212481386687392,1.2660499279438426,1.9097988512603146,"['EGR1', 'RYR2', 'NTRK2', 'ADCYAP1R1', 'CHRNA4', 'YWHAB', 'MBD1', 'YBX1', 'NFKB1', 'GCK', 'HSP90B1', 'SOX2', 'YWHAQ', 'SST', 'TPPP', 'SCN3B', 'ALDOA']",0.9893137093947314,0,0,17
91,Aflatoxin B1 metabolism WP699,0.22687178899273508,7.287246049661399,10.809683828809414,['AKR7A2'],0.9893137093947314,0,0,1
92,Arylamine metabolism WP694,0.22687178899273508,7.287246049661399,10.809683828809414,['SULT1A1'],0.9893137093947314,0,0,1
93,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.23423817733353836,1.988135593220339,2.8856134591921108,"['CD63', 'CD81', 'SOD1']",0.9893137093947314,0,0,3
94,TP53 network WP1742,0.23423817733353836,1.988135593220339,2.8856134591921108,"['SUMO1', 'GADD45A', 'BAX']",0.9893137093947314,0,0,3
95,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.24286116695816848,1.7154257972267482,2.42778265409098,"['TGFBR3', 'RUNX2', 'FBN1', 'ENG']",0.9893137093947314,0,0,4
96,Type II interferon signaling (IFNG) WP619,0.24286116695816848,1.7154257972267482,2.42778265409098,"['STAT1', 'TAP1', 'EIF2AK2', 'ISG15']",0.9893137093947314,0,0,4
97,Unfolded protein response WP4925,0.24286116695816848,1.7154257972267482,2.42778265409098,"['ERN1', 'XBP1', 'HSPA5', 'DDIT3']",0.9893137093947314,0,0,4
98,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.24407893349017712,1.5850629549478654,2.2353566018986,"['STAT1', 'EIF2AK2', 'FOS', 'NFKB1', 'IFNAR1']",0.9893137093947314,0,0,5
99,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.24407893349017712,1.5850629549478654,2.2353566018986,"['CAMK2D', 'STAR', 'CALM3', 'CALM1', 'CAMK1G']",0.9893137093947314,0,0,5
100,Autosomal recessive Osteopetrosis pathways WP4788,0.25026489010598363,2.429512516469038,3.3654466493450874,"['OSTM1', 'NFKB1']",0.9893137093947314,0,0,2
101,"Degradation pathway of sphingolipids, including diseases WP4153",0.25026489010598363,2.429512516469038,3.3654466493450874,"['NEU3', 'NEU1']",0.9893137093947314,0,0,2
102,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.25026489010598363,2.429512516469038,3.3654466493450874,"['ELOB', 'ELOC']",0.9893137093947314,0,0,2
103,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.25026489010598363,2.429512516469038,3.3654466493450874,"['SQSTM1', 'NFKB1']",0.9893137093947314,0,0,2
104,Chemokine signaling pathway WP3929,0.25032602819774563,1.2419622422165442,1.7201066494542352,"['STAT1', 'PXN', 'BRAF', 'CXCL14', 'NFKB1', 'GNAI2', 'CDC42', 'GNG3', 'GNG4', 'AKT3', 'GNB1', 'GRB2', 'GNB5', 'RAC1', 'PLCB1', 'NFKBIB']",0.9893137093947314,0,0,16
105,Melatonin metabolism and effects WP3298,0.26803634925369496,1.5189008295625943,1.9998344639951298,"['SULT1A1', 'CRY2', 'CRY1', 'CALM1', 'NFKB1']",0.9893137093947314,0,0,5
106,G1 to S cell cycle control WP45,0.2695048638760077,1.3567165162395414,1.7788844221885245,"['CDKN1B', 'CCND2', 'ORC6', 'CDK6', 'CCND1', 'GADD45A', 'MCM4', 'MCM6']",0.9893137093947314,0,0,8
107,Estrogen signaling pathway WP712,0.2707523863565073,1.6199987437975,2.1166102971178913,"['GNB1', 'BRAF', 'FOS', 'NFKB1']",0.9893137093947314,0,0,4
108,Physiological and pathological hypertrophy of the heart WP1528,0.2707523863565073,1.6199987437975,2.1166102971178913,"['CAMK2D', 'RAC1', 'FOS', 'CALM1']",0.9893137093947314,0,0,4
109,SARS-CoV-2 mitochondrial interactions WP5038,0.2707523863565073,1.6199987437975,2.1166102971178913,"['TOMM70', 'ACAD9', 'PHB', 'NFKB1']",0.9893137093947314,0,0,4
110,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.2707523863565073,1.6199987437975,2.1166102971178913,"['ADAMTS2', 'CRTAP', 'PLOD2', 'PPIB']",0.9893137093947314,0,0,4
111,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.27718994294106647,1.3794955771173212,1.7699649636809323,"['TGFBR3', 'STAT1', 'FOS', 'RUNX2', 'NFKB1', 'ENG', 'FBN1']",0.9893137093947314,0,0,7
112,CAMKK2  Pathway WP4874,0.2924749413986383,1.4580316742081447,1.792469565109303,"['MAP1LC3A', 'RAC1', 'CALM1', 'SQSTM1', 'CAMKK2']",0.9893137093947314,0,0,5
113,Osteoclast Signaling WP12,0.2976506592247376,2.0822779704767282,2.5233768342269265,"['ATP6V1G1', 'IFNAR1']",0.9893137093947314,0,0,2
114,Purine metabolism WP4792,0.2976506592247376,2.0822779704767282,2.5233768342269265,"['PRPS1', 'ITPA']",0.9893137093947314,0,0,2
115,Apoptosis Modulation and Signaling WP1772,0.30246777934125424,1.2572613296301367,1.5034086087321457,"['HRK', 'TRADD', 'MADD', 'BAX', 'FOS', 'PRKD1', 'CFLAR', 'PTPN13', 'NFKB1', 'BCL2L2']",0.9893137093947314,0,0,10
116,Urea cycle and metabolism of amino groups WP497,0.3031430086576854,1.6820078226857889,2.007561461194091,"['ODC1', 'SMS', 'SRM']",0.9893137093947314,0,0,3
117,IL-18 signaling pathway WP4754,0.3039192501372419,1.1400529176201373,1.3577953151738813,"['CD83', 'ANP32A', 'EPB41', 'CD81', 'RGS16', 'KLC1', 'CENPB', 'TMSB4X', 'B2M', 'ABCF1', 'HPS1', 'NDUFC1', 'FOS', 'CFLAR', 'RUNX2', 'NFKB1', 'SLC4A7', 'BMP2', 'NACA', 'SYT10', 'ZNF219', 'BAX', 'LTB', 'AARS', 'ITM2C']",0.9893137093947314,0,0,25
118,IL-6 signaling pathway WP364,0.3069432766990832,1.3669354838709677,1.6144769949898954,"['NCOA1', 'STAT1', 'GAB1', 'GRB2', 'RAC1', 'VIP']",0.9893137093947314,0,0,6
119,PDGF Pathway WP2526,0.3069432766990832,1.3669354838709677,1.6144769949898954,"['CDC42', 'STAT1', 'GRB2', 'RAC1', 'FOS', 'NFKB1']",0.9893137093947314,0,0,6
120,miRNA regulation of prostate cancer signaling pathways WP3981,0.31727189020158003,1.4018447615732683,1.6093124241186543,"['CDKN1B', 'CCND1', 'AKT3', 'GRB2', 'NFKB1']",0.9893137093947314,0,0,5
121,Neural Crest Cell Migration in Cancer WP4565,0.31727189020158003,1.4018447615732683,1.6093124241186543,"['NTRK2', 'ARF1', 'AKT3', 'RAC1', 'FOS']",0.9893137093947314,0,0,5
122,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.3202156454215482,3.6433408577878104,4.148893087561436,['VIP'],0.9893137093947314,0,0,1
123,GABA metabolism (aka GHB) WP4157,0.3202156454215482,3.6433408577878104,4.148893087561436,['AKR7A2'],0.9893137093947314,0,0,1
124,Nanomaterial-induced inflammasome activation WP3890,0.3202156454215482,3.6433408577878104,4.148893087561436,['NFKB1'],0.9893137093947314,0,0,1
125,Steroid Biosynthesis WP496,0.3202156454215482,3.6433408577878104,4.148893087561436,['HSD17B1'],0.9893137093947314,0,0,1
126,Metabolic reprogramming in colon cancer WP4290,0.3292276952001595,1.325410299943407,1.4725383780890222,"['MDH2', 'IDH2', 'TALDO1', 'PYCR2', 'TKT', 'GLS']",0.9893137093947314,0,0,6
127,Ebstein-Barr virus LMP1 signaling WP262,0.33801860522481775,1.5617433414043584,1.6939516931738015,"['HSP90AA1', 'TRADD', 'NFKB1']",0.9893137093947314,0,0,3
128,"GPCRs, Class B Secretin-like WP334",0.33801860522481775,1.5617433414043584,1.6939516931738015,"['ADCYAP1R1', 'ADGRE5', 'ADGRL3']",0.9893137093947314,0,0,3
129,Imatinib and Chronic Myeloid Leukemia WP3640,0.33801860522481775,1.5617433414043584,1.6939516931738015,"['CDKN1B', 'FLT1', 'GADD45A']",0.9893137093947314,0,0,3
130,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.33801860522481775,1.5617433414043584,1.6939516931738015,"['RAB5C', 'MRAS', 'BRAF']",0.9893137093947314,0,0,3
131,IL-2 signaling pathway WP49,0.34230796611885006,1.3498198424669012,1.4470668859854885,"['CCND2', 'STAT1', 'GRB2', 'FOS', 'MAPT']",0.9893137093947314,0,0,5
132,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.34452756085732084,1.8218520609824957,1.9413312857608136,"['GABBR1', 'GRM5']",0.9893137093947314,0,0,2
133,Non-homologous end joining WP438,0.34452756085732084,1.8218520609824957,1.9413312857608136,"['XRCC6', 'XRCC5']",0.9893137093947314,0,0,2
134,Transcriptional cascade regulating adipogenesis WP4211,0.34452756085732084,1.8218520609824957,1.9413312857608136,"['DDIT3', 'PPARG']",0.9893137093947314,0,0,2
135,Apoptosis WP254,0.3485517288975453,1.2150415721844294,1.280615697346361,"['HRK', 'TRADD', 'BAX', 'TRAF2', 'CFLAR', 'TNFRSF21', 'NFKB1', 'BCL2L2', 'NFKBIB']",0.9893137093947314,0,0,9
136,Calcium Regulation in the Cardiac Cell WP536,0.35058880977804063,1.1373064303776306,1.1920577543990265,"['RYR2', 'RGS17', 'CAMK2D', 'YWHAB', 'RGS16', 'ATP1B2', 'GNAI2', 'GNG3', 'YWHAQ', 'GNG4', 'FXYD2', 'GNB1', 'CALM3', 'PRKD1', 'CALR', 'GNB5', 'CALM1']",0.9893137093947314,0,0,17
137,Splicing factor NOVA regulated synaptic proteins WP4148,0.35170572575580783,1.2863277738939378,1.3441616615572238,"['NTNG1', 'CADM1', 'EPB41', 'APLP2', 'CLSTN1', 'EFNA5']",0.9893137093947314,0,0,6
138,TGF-beta Receptor Signaling WP560,0.35170572575580783,1.2863277738939378,1.3441616615572238,"['TGFBR3', 'STAT1', 'FOS', 'RUNX2', 'NFKB1', 'ENG']",0.9893137093947314,0,0,6
139,Aryl Hydrocarbon Receptor Pathway WP2873,0.35673371965843875,1.3882473283264691,1.4309576719896877,"['NCOA1', 'HSP90AA1', 'CDKN1B', 'BAX']",0.9893137093947314,0,0,4
140,Gastric Cancer Network 2 WP2363,0.35673371965843875,1.3882473283264691,1.4309576719896877,"['OTUD5', 'DSCC1', 'RAD17', 'CEBPZ']",0.9893137093947314,0,0,4
141,Pathogenic Escherichia coli infection WP2272,0.3582237551847832,1.2445239344805679,1.2776251266476695,"['CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC3', 'ARPC5', 'ACTG1']",0.9893137093947314,0,0,7
142,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.36367847619613686,1.1218058294981372,1.1346898915523298,"['EGR1', 'NTRK2', 'RAB3A', 'CSNK2A1', 'STAT1', 'YBX1', 'FOS', 'EIF2S2', 'NFKB1', 'CDC42', 'BMP2', 'DPYSL2', 'RACK1', 'KCNN2', 'GRB2', 'RAC1', 'MAPT', 'SQSTM1']",0.9893137093947314,0,0,18
143,Oxidative Damage WP3941,0.36746875322691575,1.301510989010989,1.3029647626994323,"['CDC42', 'CDKN1B', 'GADD45A', 'TRAF2', 'NFKB1']",0.9893137093947314,0,0,5
144,Hippo-Yap signaling pathway WP4537,0.37277533544673425,1.4575141242937852,1.4382448527819194,"['YWHAQ', 'TNIK', 'TEAD1']",0.9893137093947314,0,0,3
145,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.37277533544673425,1.4575141242937852,1.4382448527819194,"['STAT1', 'EIF2AK2', 'IFNAR1']",0.9893137093947314,0,0,3
146,Endothelin Pathways WP2197,0.38557477900038545,1.3250423968343696,1.2627920713789866,"['RIIAD1', 'GNB5', 'PLCB1', 'CALM1']",0.9893137093947314,0,0,4
147,Senescence and Autophagy in Cancer WP615,0.38709583931422054,1.1454840278903844,1.087159383054391,"['GABARAPL2', 'RSL1D1', 'GABARAPL1', 'BMP2', 'MAP1LC3B', 'CDKN1B', 'MAP1LC3A', 'BRAF', 'CXCL14', 'SQSTM1', 'GABARAP']",0.9893137093947314,0,0,11
148,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.39032811790894184,1.619298575820315,1.5233835791617905,"['BMP2', 'RUNX2']",0.9893137093947314,0,0,2
149,Cancer immunotherapy by PD-1 blockade WP4585,0.39032811790894184,1.619298575820315,1.5233835791617905,"['HLA-A', 'NFKB1']",0.9893137093947314,0,0,2
150,Computational Model of Aerobic Glycolysis WP4629,0.39032811790894184,1.619298575820315,1.5233835791617905,"['ALDOA', 'PFKM']",0.9893137093947314,0,0,2
151,Ganglio Sphingolipid Metabolism WP1423,0.39032811790894184,1.619298575820315,1.5233835791617905,"['ST8SIA1', 'ST8SIA3']",0.9893137093947314,0,0,2
152,"NAD metabolism, sirtuins and aging WP3630",0.39032811790894184,1.619298575820315,1.5233835791617905,"['PPARG', 'NFKB1']",0.9893137093947314,0,0,2
153,RAS and bradykinin pathways in COVID-19 WP4969,0.39032811790894184,1.619298575820315,1.5233835791617905,"['PRKG1', 'NFKB1']",0.9893137093947314,0,0,2
154,Serotonin and anxiety-related events WP3944,0.39032811790894184,1.619298575820315,1.5233835791617905,"['ARC', 'FOS']",0.9893137093947314,0,0,2
155,DNA Replication WP466,0.39264564483434217,1.2565337806210017,1.1746677662375777,"['ORC6', 'UBC', 'MCM4', 'MCM6', 'UBA52']",0.9893137093947314,0,0,5
156,Eukaryotic Transcription Initiation WP405,0.3969193943722164,1.214676476136578,1.1223878545575916,"['TAF12', 'POLR2E', 'POLR2F', 'POLR1E', 'POLR2G', 'GTF2H3']",0.9893137093947314,0,0,6
157,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.3969193943722164,1.214676476136578,1.1223878545575916,"['HSP90AA1', 'CCND1', 'BAX', 'TRAF2', 'FOS', 'CFLAR']",0.9893137093947314,0,0,6
158,Cardiac Hypertrophic Response WP2795,0.3996086540304008,1.1864547393926623,1.0882988354012417,"['CAMK2D', 'RAC1', 'PRKD1', 'CALM1', 'PRKG1', 'NFKB1', 'FGFR2']",0.9893137093947314,0,0,7
159,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.4022951802137444,2.4287057938299474,2.2115046447895303,['NFKB1'],0.9893137093947314,0,0,1
160,Macrophage markers WP4146,0.4022951802137444,2.4287057938299474,2.2115046447895303,['CD83'],0.9893137093947314,0,0,1
161,Vitamin B6-dependent and responsive disorders WP4228,0.4022951802137444,2.4287057938299474,2.2115046447895303,['PNPO'],0.9893137093947314,0,0,1
162,Ovarian infertility WP34,0.40715858910082575,1.366313559322034,1.2277044858606654,"['EGR1', 'CDKN1B', 'CCND2']",0.9893137093947314,0,0,3
163,Triacylglyceride synthesis WP325,0.40715858910082575,1.366313559322034,1.2277044858606654,"['DGAT2', 'AGPAT1', 'PLPP1']",0.9893137093947314,0,0,3
164,Pre-implantation embryo WP3527,0.4142438371541227,1.2673335463415834,1.1169016879353337,"['SOX2', 'EGR1', 'DDIT3', 'FOSB']",0.9893137093947314,0,0,4
165,Corticotropin-releasing hormone signaling pathway WP2355,0.4199618787893922,1.1212531087743793,0.972789483321091,"['ERN1', 'HSP90AA1', 'STAR', 'GNB1', 'FOSB', 'BRAF', 'FOS', 'GNB5', 'NFKB1', 'GNAI2']",0.9893137093947314,0,0,10
166,Head and Neck Squamous Cell Carcinoma WP4674,0.4203726899544977,1.1308937368050669,0.9800478971505334,"['CDK6', 'CCND1', 'SESN1', 'SESN2', 'AKT3', 'GAB1', 'FAT1', 'NFKB1', 'FGFR2']",0.9893137093947314,0,0,9
167,DNA Repair Pathways Full Network WP4946,0.42974702676656445,1.082435035312405,0.9141797674234036,"['XRCC6', 'MRE11', 'XRCC5', 'MGMT', 'REV1', 'FANCC', 'RAD23A', 'GTF2H3', 'GTF2H5', 'FANCF', 'DDB1', 'NEIL2', 'MSH2', 'POLE3', 'USP1']",0.9893137093947314,0,0,15
168,Gastrin signaling pathway WP4659,0.43262426902159956,1.0890216823406478,0.9124756583186641,"['EGR1', 'CDKN1B', 'PXN', 'FOS', 'NFKB1', 'CDC42', 'BMP2', 'CCND1', 'GRB2', 'PPARG', 'PRKD1', 'RAC1', 'MEF2D']",0.9893137093947314,0,0,13
169,Biomarkers for pyrimidine metabolism disorders WP4584,0.4346291399095739,1.4572557876905703,1.2142761103577164,"['TK2', 'UMPS']",0.9893137093947314,0,0,2
170,Genes targeted by miRNAs in adipocytes WP1992,0.4346291399095739,1.4572557876905703,1.2142761103577164,"['TMSB4X', 'KCNJ2']",0.9893137093947314,0,0,2
171,NO metabolism in cystic fibrosis WP4947,0.4346291399095739,1.4572557876905703,1.2142761103577164,"['PRMT5', 'PRMT2']",0.9893137093947314,0,0,2
172,miRNA regulation of p53 pathway in prostate cancer WP3982,0.44094975051727736,1.2858424725822533,1.0528791325143292,"['EI24', 'SHISA5', 'BAX']",0.9893137093947314,0,0,3
173,Neural Crest Cell Migration during Development WP4564,0.4426046440638434,1.2144337667231957,0.9898586813693797,"['ARF1', 'AKT3', 'RAC1', 'FOS']",0.9893137093947314,0,0,4
174,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4426046440638434,1.2144337667231957,0.9898586813693797,"['NDUFA13', 'HSP90AA1', 'COPS6', 'RAC1']",0.9893137093947314,0,0,4
175,Ferroptosis WP4313,0.442646859994211,1.1752846299810247,0.9578369731504458,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'LPCAT3', 'SLC3A2']",0.9893137093947314,0,0,5
176,Folate Metabolism WP176,0.442646859994211,1.1752846299810247,0.9578369731504458,"['AHCY', 'GPX4', 'MTHFD1', 'NFKB1', 'SOD1']",0.9893137093947314,0,0,5
177,Amino Acid metabolism WP3925,0.4562821540753985,1.0930272108843537,0.8576371356124333,"['WARS', 'MDH2', 'RARS', 'ODC1', 'SMS', 'IARS', 'HNMT', 'GLS', 'SRM']",0.9893137093947314,0,0,9
178,Endometrial cancer WP4155,0.4587866224061217,1.099877064514405,0.8569912694871067,"['CCND1', 'GADD45A', 'AKT3', 'BAX', 'BRAF', 'GRB2', 'FOS', 'FGFR2']",0.9893137093947314,0,0,8
179,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4672890929791327,1.138468608597285,0.8661550803082667,"['STAT1', 'TRADD', 'TRAF2', 'NFKB1', 'IFNAR1']",0.9893137093947314,0,0,5
180,Glycolysis and Gluconeogenesis WP534,0.47053555963111876,1.1657659694742792,0.8788520141911279,"['MDH2', 'ALDOA', 'PFKM', 'GCK']",0.9893137093947314,0,0,4
181,PDGFR-beta pathway WP3972,0.47053555963111876,1.1657659694742792,0.8788520141911279,"['STAT1', 'EIF2AK2', 'GRB2', 'FOS']",0.9893137093947314,0,0,4
182,Prion disease pathway WP3995,0.47053555963111876,1.1657659694742792,0.8788520141911279,"['PDIA3', 'HSPA5', 'NFKB1', 'HSP90B1']",0.9893137093947314,0,0,4
183,IL-7 signaling pathway WP205,0.47396450011586494,1.2143126177024481,0.9066335527169198,"['CDKN1B', 'CCND1', 'STAT1']",0.9893137093947314,0,0,3
184,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.4744690427168935,1.8213882618510158,1.3579522380195264,['PPARG'],0.9893137093947314,0,0,1
185,FTO Obesity Variant Mechanism WP3407,0.4744690427168935,1.8213882618510158,1.3579522380195264,['ARID5B'],0.9893137093947314,0,0,1
186,miR-517 relationship with ARCN1 and USP1 WP3596,0.4744690427168935,1.8213882618510158,1.3579522380195264,['USP1'],0.9893137093947314,0,0,1
187,"Phase I biotransformations, non P450 WP136",0.4744690427168935,1.8213882618510158,1.3579522380195264,['CES2'],0.9893137093947314,0,0,1
188,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4744690427168935,1.8213882618510158,1.3579522380195264,['DLL3'],0.9893137093947314,0,0,1
189,Tgif disruption of Shh signaling WP3674,0.4744690427168935,1.8213882618510158,1.3579522380195264,['GLI3'],0.9893137093947314,0,0,1
190,Airway smooth muscle cell contraction WP4962,0.47712518724439057,1.3246753246753247,0.9802284454327855,"['PLCB1', 'CALM1']",0.9893137093947314,0,0,2
191,Cori Cycle WP1946,0.47712518724439057,1.3246753246753247,0.9802284454327855,"['TALDO1', 'ALDOA']",0.9893137093947314,0,0,2
192,GPR40 Pathway WP3958,0.47712518724439057,1.3246753246753247,0.9802284454327855,"['PLCL1', 'PLCB1']",0.9893137093947314,0,0,2
193,Pyrimidine metabolism and related diseases WP4225,0.47712518724439057,1.3246753246753247,0.9802284454327855,"['TK2', 'UMPS']",0.9893137093947314,0,0,2
194,Toll-like Receptor Signaling Pathway WP75,0.4777445781666119,1.079425034099255,0.7973486529158301,"['STAT1', 'AKT3', 'TAB2', 'RAC1', 'FOS', 'NFKB1', 'IFNAR1', 'NFKBIB']",0.9893137093947314,0,0,8
195,Small cell lung cancer WP4658,0.48368475444478776,1.0545582173367585,0.7659487473405487,"['CDKN1B', 'CDK6', 'CCND1', 'COL4A1', 'GADD45A', 'AKT3', 'BAX', 'TRAF2', 'NFKB1', 'SKP1', 'NFKBIB']",0.9893137093947314,0,0,11
196,Modulators of TCR signaling and T cell activation WP5072,0.4863158238637081,1.0928692699490663,0.787846203013086,"['CDKN1B', 'CBLB', 'ELOB', 'GRB2', 'MEF2D', 'NFKB1']",0.9893137093947314,0,0,6
197,Spinal Cord Injury WP2431,0.4875587880538703,1.0559241082805166,0.7585171752192849,"['CDC42', 'EGR1', 'CDKN1B', 'CCND1', 'COL4A1', 'GADD45A', 'RAC1', 'FOS', 'LTB', 'SLIT2']",0.9893137093947314,0,0,10
198,Integrated Cancer Pathway WP1971,0.49158390292300425,1.1038838612368025,0.7838929285107687,"['MRE11', 'CDKN1B', 'MSH2', 'STAT1', 'BAX']",0.9893137093947314,0,0,5
199,22q11.2 copy number variation syndrome WP4657,0.49956398608346037,1.040781579374088,0.7223228037795416,"['CDC42', 'CBX5', 'MRPL40', 'XPO1', 'HIRIP3', 'TXNRD2', 'EMC10', 'HIST1H4C', 'KPNB1', 'FGFR2', 'DGCR2']",0.9893137093947314,0,0,11
200,Oncostatin M Signaling Pathway WP2374,0.5018832536064276,1.062452812382031,0.73244195261318,"['EGR1', 'CDKN1B', 'STAT1', 'PXN', 'GRB2', 'FOS', 'NFKB1']",0.9893137093947314,0,0,7
201,Endochondral Ossification with Skeletal Dysplasias WP4808,0.508071038359607,1.0661311027371734,0.721913620135493,"['THRA', 'STAT1', 'SOX6', 'CALM1', 'GLI3', 'RUNX2']",0.9893137093947314,0,0,6
202,Endochondral Ossification WP474,0.508071038359607,1.0661311027371734,0.721913620135493,"['THRA', 'STAT1', 'SOX6', 'CALM1', 'GLI3', 'RUNX2']",0.9893137093947314,0,0,6
203,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5176063339001773,1.2141916054959534,0.7995941027011616,"['MADD', 'GCC2']",0.9893137093947314,0,0,2
204,Differentiation of white and brown adipocyte WP2895,0.5176063339001773,1.2141916054959534,0.7995941027011616,"['BMP2', 'PPARG']",0.9893137093947314,0,0,2
205,GDNF/RET signaling axis WP4830,0.5176063339001773,1.2141916054959534,0.7995941027011616,"['SLIT2', 'GLI3']",0.9893137093947314,0,0,2
206,IL-9 signaling pathway WP22,0.5176063339001773,1.2141916054959534,0.7995941027011616,"['STAT1', 'GRB2']",0.9893137093947314,0,0,2
207,Serotonin and anxiety WP3947,0.5176063339001773,1.2141916054959534,0.7995941027011616,"['ARC', 'FOS']",0.9893137093947314,0,0,2
208,Transcription co-factors SKI and SKIL protein partners WP4533,0.5176063339001773,1.2141916054959534,0.7995941027011616,"['PRMT5', 'TEAD1']",0.9893137093947314,0,0,2
209,MET in type 1 papillary renal cell carcinoma WP4205,0.5217339377174954,1.0406892088658792,0.6770698172329083,"['CDC42', 'AKT3', 'RPL11', 'GAB1', 'BRAF', 'GRB2', 'RAC1']",0.9893137093947314,0,0,7
210,Cell cycle WP179,0.5254024121128656,1.016441503902381,0.6541724115647394,"['STAG1', 'CCND2', 'ORC6', 'CDK6', 'CDKN1B', 'CCND1', 'YWHAQ', 'GADD45A', 'YWHAB', 'MCM4', 'MCM6', 'SKP1']",0.9893137093947314,0,0,12
211,Ebola Virus Pathway on Host WP4217,0.5254024121128656,1.016441503902381,0.6541724115647394,"['CDC42', 'STAT1', 'VPS33A', 'VPS4A', 'EIF2AK2', 'CLTA', 'HLA-A', 'RAC1', 'HLA-F', 'CLEC4G', 'NFKB1', 'ACTG1']",0.9893137093947314,0,0,12
212,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.529477782503729,1.0406661815829896,0.661722238113517,"['WNT10B', 'BMP2', 'FNTA', 'PPARG', 'EMD', 'RUNX2']",0.9893137093947314,0,0,6
213,G Protein Signaling Pathways WP35,0.5370181108013649,1.011690930862797,0.6289919851316508,"['GNG3', 'GNG4', 'PDE4D', 'GNB1', 'AKAP6', 'PRKD1', 'AKAP5', 'GNB5', 'CALM1', 'GNAI2']",0.9893137093947314,0,0,10
214,Pathways Regulating Hippo Signaling WP4540,0.5370181108013649,1.011690930862797,0.6289919851316508,"['CDC42', 'NTRK2', 'FLT1', 'PRKAG1', 'RAC1', 'PLCB1', 'TEAD1', 'FGFR2', 'CDH18', 'GNAI2']",0.9893137093947314,0,0,10
215,16p11.2 distal deletion syndrome WP4950,0.5370854093076317,1.0927118644067797,0.679227671355173,"['CD81', 'TRAF2', 'GRB2']",0.9893137093947314,0,0,3
216,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5370854093076317,1.0927118644067797,0.679227671355173,"['CBX5', 'RBBP4', 'H3F3B']",0.9893137093947314,0,0,3
217,Sleep regulation WP3591,0.5370854093076317,1.0927118644067797,0.679227671355173,"['AHCY', 'STAR', 'FOS']",0.9893137093947314,0,0,3
218,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.5379320920732776,1.456997742663657,0.9033720381114813,['STAR'],0.9893137093947314,0,0,1
219,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.5379320920732776,1.456997742663657,0.9033720381114813,['RUNX2'],0.9893137093947314,0,0,1
220,Irinotecan pathway WP229,0.5379320920732776,1.456997742663657,0.9033720381114813,['CES2'],0.9893137093947314,0,0,1
221,Methylation Pathways WP704,0.5379320920732776,1.456997742663657,0.9033720381114813,['HNMT'],0.9893137093947314,0,0,1
222,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5379320920732776,1.456997742663657,0.9033720381114813,['HIF1AN'],0.9893137093947314,0,0,1
223,Molybdenum cofactor (Moco) biosynthesis WP4507,0.5379320920732776,1.456997742663657,0.9033720381114813,['SUOX'],0.9893137093947314,0,0,1
224,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5379320920732776,1.456997742663657,0.9033720381114813,['NFKB1'],0.9893137093947314,0,0,1
225,Small Ligand GPCRs WP247,0.5379320920732776,1.456997742663657,0.9033720381114813,['LPAR1'],0.9893137093947314,0,0,1
226,Tamoxifen metabolism WP691,0.5379320920732776,1.456997742663657,0.9033720381114813,['SULT1A1'],0.9893137093947314,0,0,1
227,Regulation of Microtubule Cytoskeleton WP2038,0.5388532316698226,1.0406431803490628,0.6434422104712623,"['CDC42', 'DPYSL2', 'TPPP', 'RAC1', 'MAPT']",0.9893137093947314,0,0,5
228,Development of ureteric collection system WP5053,0.5507486332565527,1.0406202051199225,0.6207057838528302,"['CCND1', 'SLIT2', 'GLI3', 'FGFR2']",0.9893137093947314,0,0,4
229,MAPK pathway in congenital thyroid cancer WP4928,0.5559395786592102,1.1207053815749468,0.6579612680293099,"['BRAF', 'FOS']",0.9893137093947314,0,0,2
230,Overview of interferons-mediated signaling pathway WP4558,0.5559395786592102,1.1207053815749468,0.6579612680293099,"['STAT1', 'IFNAR1']",0.9893137093947314,0,0,2
231,SARS coronavirus and innate immunity WP4912,0.5559395786592102,1.1207053815749468,0.6579612680293099,"['STAT1', 'IFNAR1']",0.9893137093947314,0,0,2
232,Breast cancer pathway WP4262,0.5567743389634399,0.9899380164148871,0.5797030077856501,"['NCOA1', 'WNT10B', 'MRE11', 'CSNK2A1', 'GADD45A', 'BRAF', 'FOS', 'DLL3', 'CDK6', 'CCND1', 'AKT3', 'BAX', 'GRB2', 'SKP1']",0.9893137093947314,0,0,14
233,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.5669731240373223,1.040597255851493,0.5904800206084166,"['BMP2', 'THRA', 'STAT1']",0.9893137093947314,0,0,3
234,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5693517089111989,0.9875642195227349,0.5562523788301746,"['CCND1', 'MSH2', 'GADD45A', 'AKT3', 'BAX', 'BRAF', 'RAC1', 'FOS']",0.9893137093947314,0,0,8
235,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5710639539706519,0.9932088285229203,0.5564492906721346,"['OTUD5', 'TRADD', 'TRAF2', 'ISG15', 'NFKB1', 'NFKBIB']",0.9893137093947314,0,0,6
236,Amyotrophic lateral sclerosis (ALS) WP2447,0.5760286009721929,1.0046587785813141,0.5541677378384624,"['CCS', 'BAX', 'RAC1', 'SOD1']",0.9893137093947314,0,0,4
237,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5760286009721929,1.0046587785813141,0.5541677378384624,"['TRAF2', 'RAC1', 'NFKB1', 'NFKBIB']",0.9893137093947314,0,0,4
238,Prolactin Signaling Pathway WP2037,0.5868175028281097,0.9710292728989612,0.517598808476692,"['STAT1', 'PXN', 'GRB2', 'RAC1', 'FOS', 'PPIB', 'NFKB1', 'NFKBIB']",0.9893137093947314,0,0,8
239,Notch Signaling Pathway Netpath WP61,0.591164871688802,0.9710620637615545,0.5104488046664618,"['CCND1', 'CIR1', 'MAPT', 'NFKB1', 'SKP1', 'DLL3']",0.9893137093947314,0,0,6
240,BMP Signaling Pathway in Eyelid Development WP3927,0.5920533488131545,1.0405743324997982,0.5454259144766439,"['SFRP1', 'FGFR2']",0.9893137093947314,0,0,2
241,Globo Sphingolipid Metabolism WP1424,0.5920533488131545,1.0405743324997982,0.5454259144766439,"['B3GALNT1', 'ST8SIA1']",0.9893137093947314,0,0,2
242,miRNA targets in ECM and membrane receptors WP2911,0.5920533488131545,1.0405743324997982,0.5454259144766439,"['COL4A1', 'SDC2']",0.9893137093947314,0,0,2
243,Glioblastoma signaling pathways WP2261,0.5936885232125668,0.9638355342136855,0.5025442994298608,"['CDKN1B', 'CCND2', 'CDK6', 'CCND1', 'AKT3', 'GAB1', 'BRAF', 'GRB2', 'FGFR2']",0.9893137093947314,0,0,9
244,Aspirin and miRNAs WP4707,0.5937351312392471,1.2140707298720843,0.6329217398452202,['NFKB1'],0.9893137093947314,0,0,1
245,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.5937351312392471,1.2140707298720843,0.6329217398452202,['MRE11'],0.9893137093947314,0,0,1
246,Estrogen metabolism WP697,0.5937351312392471,1.2140707298720843,0.6329217398452202,['SULT1A1'],0.9893137093947314,0,0,1
247,Glial Cell Differentiation WP2276,0.5937351312392471,1.2140707298720843,0.6329217398452202,['TPPP'],0.9893137093947314,0,0,1
248,Insulin signaling in adipocytes (diabetic condition) WP3635,0.5937351312392471,1.2140707298720843,0.6329217398452202,['TBC1D4'],0.9893137093947314,0,0,1
249,Insulin signaling in adipocytes (normal condition) WP3634,0.5937351312392471,1.2140707298720843,0.6329217398452202,['TBC1D4'],0.9893137093947314,0,0,1
250,Liver X receptor pathway WP2874,0.5937351312392471,1.2140707298720843,0.6329217398452202,['ABCG8'],0.9893137093947314,0,0,1
251,LTF danger signal response pathway WP4478,0.5937351312392471,1.2140707298720843,0.6329217398452202,['NFKB1'],0.9893137093947314,0,0,1
252,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5937351312392471,1.2140707298720843,0.6329217398452202,['BAX'],0.9893137093947314,0,0,1
253,Mevalonate pathway WP3963,0.5937351312392471,1.2140707298720843,0.6329217398452202,['PMVK'],0.9893137093947314,0,0,1
254,Role of Osx and miRNAs in tooth development WP3971,0.5937351312392471,1.2140707298720843,0.6329217398452202,['RUNX2'],0.9893137093947314,0,0,1
255,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5937351312392471,1.2140707298720843,0.6329217398452202,['NFKB1'],0.9893137093947314,0,0,1
256,Type III interferon signaling WP2113,0.5937351312392471,1.2140707298720843,0.6329217398452202,['STAT1'],0.9893137093947314,0,0,1
257,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5956421138491194,0.9932203389830508,0.5146026264815567,"['RAB3B', 'RAB3A', 'SBF2']",0.9893137093947314,0,0,3
258,Sphingolipid pathway WP1422,0.5956421138491194,0.9932203389830508,0.5146026264815567,"['ASAH1', 'SGPL1', 'PLPP1']",0.9893137093947314,0,0,3
259,IL-5 signaling pathway WP127,0.6004796451630495,0.9710947804786132,0.4952841055758121,"['STAT1', 'GRB2', 'FOS', 'MAPT']",0.9893137093947314,0,0,4
260,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6004796451630495,0.9710947804786132,0.4952841055758121,"['PXN', 'GAB1', 'GRB2', 'FOS']",0.9893137093947314,0,0,4
261,Target Of Rapamycin (TOR) Signaling WP1471,0.6004796451630495,0.9710947804786132,0.4952841055758121,"['CDC42', 'PRKAG1', 'ULK2', 'RAC1']",0.9893137093947314,0,0,4
262,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6039368824012831,0.9550364556726885,0.48161111855068894,"['WNT10B', 'CDK8', 'SFRP1', 'CCND2', 'CDK6', 'CCND1', 'CSNK2A1', 'NKD1']",0.9893137093947314,0,0,8
263,ErbB signaling pathway WP673,0.6151861027300319,0.945628393161008,0.459415068620496,"['CAMK2D', 'CDKN1B', 'CCND1', 'NRG3', 'ERBB4', 'AKT3', 'GAB1', 'CBLB', 'BRAF', 'GRB2']",0.9893137093947314,0,0,10
264,Osteoblast differentiation WP4787,0.6151861027300319,0.945628393161008,0.459415068620496,"['WNT10B', 'BMP2', 'STAT1', 'PPARG', 'PRKD1', 'MAPK6', 'RUNX2', 'FGFR2', 'GLI3', 'DLL3']",0.9893137093947314,0,0,10
265,Vitamin D Receptor Pathway WP2877,0.6151861027300319,0.945628393161008,0.459415068620496,"['SFRP1', 'CDKN1B', 'CCND1', 'ADGRE5', 'GADD45A', 'TPM1', 'PNOC', 'GXYLT2', 'EFNA5', 'CD200']",0.9893137093947314,0,0,10
266,Leptin signaling pathway WP2034,0.6206887006707226,0.9395595357762954,0.44810000463725636,"['NCOA1', 'CDC42', 'CCND1', 'STAT1', 'BAX', 'GRB2', 'RAC1', 'NFKB1']",0.9893137093947314,0,0,8
267,Genes controlling nephrogenesis WP4823,0.6230421800983125,0.9499631540162122,0.44946657144241775,"['SLIT2', 'GLI3', 'FGFR2']",0.9893137093947314,0,0,3
268,Nanoparticle-mediated activation of receptor signaling WP2643,0.6230421800983125,0.9499631540162122,0.44946657144241775,"['PXN', 'AKT3', 'GRB2']",0.9893137093947314,0,0,3
269,One-carbon metabolism WP241,0.6230421800983125,0.9499631540162122,0.44946657144241775,"['AHCYL2', 'AHCY', 'MTHFD1']",0.9893137093947314,0,0,3
270,Resistin as a regulator of inflammation WP4481,0.6230421800983125,0.9499631540162122,0.44946657144241775,"['AKT3', 'PLCB1', 'NFKB1']",0.9893137093947314,0,0,3
271,Trans-sulfuration and one-carbon metabolism WP2525,0.6230421800983125,0.9499631540162122,0.44946657144241775,"['AHCYL2', 'AHCY', 'MTHFD1']",0.9893137093947314,0,0,3
272,Tryptophan metabolism WP465,0.6230421800983125,0.9499631540162122,0.44946657144241775,"['GCDH', 'ECHS1', 'WARS']",0.9893137093947314,0,0,3
273,White fat cell differentiation WP4149,0.6230421800983125,0.9499631540162122,0.44946657144241775,"['WNT10B', 'DDIT3', 'PPARG']",0.9893137093947314,0,0,3
274,B Cell Receptor Signaling Pathway WP23,0.6254261356537544,0.9361516034985423,0.4393565845452578,"['CDC42', 'KLF11', 'CD81', 'GAB1', 'BRAF', 'GRB2', 'RAC1', 'MEF2D', 'NFKB1']",0.9893137093947314,0,0,9
275,Nanomaterial induced apoptosis WP2507,0.6259246208793958,0.9711274233013364,0.45499779556441583,"['BAX', 'CFLAR']",0.9893137093947314,0,0,2
276,Nicotine Activity on Dopaminergic Neurons WP1602,0.6259246208793958,0.9711274233013364,0.45499779556441583,"['CHRNA4', 'GNB1']",0.9893137093947314,0,0,2
277,Proteoglycan biosynthesis WP4784,0.6259246208793958,0.9711274233013364,0.45499779556441583,"['CANT1', 'B3GAT3']",0.9893137093947314,0,0,2
278,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6259246208793958,0.9711274233013364,0.45499779556441583,"['BAX', 'BCL2L2']",0.9893137093947314,0,0,2
279,Nucleotide Excision Repair WP4753,0.626599020981787,0.9336204896159648,0.4364194627978754,"['DDB1', 'POLE3', 'RAD23A', 'GTF2H3', 'GTF2H5']",0.9893137093947314,0,0,5
280,Ectoderm Differentiation WP2858,0.6300842224436776,0.9370443294329432,0.4328224456841972,"['CTNND2', 'ARX', 'LDB2', 'PTPN13', 'CELSR2', 'GLI3', 'SOX2', 'PLCXD3', 'ARHGEF9', 'MAFB', 'ZNF219', 'UBTF', 'FGFR2']",0.9893137093947314,0,0,13
281,ATR Signaling WP3875,0.6428022658166848,1.040551435020961,0.45983853414413156,['ATRIP'],0.9893137093947314,0,0,1
282,Bile acids synthesis and enterohepatic circulation  WP4389,0.6428022658166848,1.040551435020961,0.45983853414413156,['ABCG8'],0.9893137093947314,0,0,1
283,Canonical NF-KB pathway WP4562,0.6428022658166848,1.040551435020961,0.45983853414413156,['NFKB1'],0.9893137093947314,0,0,1
284,Cell Differentiation - Index WP2029,0.6428022658166848,1.040551435020961,0.45983853414413156,['MEF2D'],0.9893137093947314,0,0,1
285,HIF1A and PPARG regulation of glycolysis WP2456,0.6428022658166848,1.040551435020961,0.45983853414413156,['PPARG'],0.9893137093947314,0,0,1
286,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.6428022658166848,1.040551435020961,0.45983853414413156,['STAT1'],0.9893137093947314,0,0,1
287,Leptin and adiponectin WP3934,0.6428022658166848,1.040551435020961,0.45983853414413156,['PRKAG1'],0.9893137093947314,0,0,1
288,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.6428022658166848,1.040551435020961,0.45983853414413156,['CCND1'],0.9893137093947314,0,0,1
289,Mitochondrial CII Assembly WP4920,0.6428022658166848,1.040551435020961,0.45983853414413156,['SDHAF1'],0.9893137093947314,0,0,1
290,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.6428022658166848,1.040551435020961,0.45983853414413156,['NFKB1'],0.9893137093947314,0,0,1
291,DNA damage response (only ATM dependent) WP710,0.6445274885690923,0.9215448351127609,0.40477733197836463,"['CDC42', 'WNT10B', 'CCND2', 'CDKN1B', 'CCND1', 'AKT3', 'BAX', 'GRB2', 'RAC1', 'NFKB1']",0.9893137093947314,0,0,10
292,Glycogen Synthesis and Degradation WP500,0.6467359180462017,0.9102600339174675,0.3967070079856317,"['PPP2R2B', 'PHKA1', 'CALM3', 'CALM1']",0.9893137093947314,0,0,4
293,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6467359180462017,0.9102600339174675,0.3967070079856317,"['CCND1', 'GRB2', 'RAC1', 'NFKB1']",0.9893137093947314,0,0,4
294,Prader-Willi and Angelman Syndrome WP3998,0.6468908964187162,0.9102092760180995,0.39646679802909746,"['CCND2', 'CDK6', 'CCND1', 'FEZ1', 'BBS4']",0.9893137093947314,0,0,5
295,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6468908964187162,0.9102092760180995,0.39646679802909746,"['TAB2', 'IL1RAP', 'FOS', 'NFKB1', 'NFKBIB']",0.9893137093947314,0,0,5
296,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6468908964187162,0.9102092760180995,0.39646679802909746,"['CSNK2A1', 'AKT3', 'EIF4G3', 'EIF4B', 'EIF4G1']",0.9893137093947314,0,0,5
297,IL17 signaling pathway WP2112,0.6491419511623686,0.9103107344632768,0.39334878515958,"['IL17RE', 'NFKB1', 'NFKBIB']",0.9893137093947314,0,0,3
298,Intraflagellar transport proteins binding to dynein WP4532,0.6491419511623686,0.9103107344632768,0.39334878515958,"['DYNC2H1', 'DYNLT1', 'WDR19']",0.9893137093947314,0,0,3
299,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6491419511623686,0.9103107344632768,0.39334878515958,"['YWHAQ', 'RAC1', 'TEAD1']",0.9893137093947314,0,0,3
300,Hepatitis B infection WP4666,0.6554832590126184,0.9187058693733451,0.3880452959894931,"['ATP6AP1', 'YWHAB', 'STAT1', 'BRAF', 'FOS', 'NFKB1', 'DDB1', 'YWHAQ', 'AKT3', 'BAX', 'GRB2', 'TAB2', 'IFNAR1']",0.9893137093947314,0,0,13
301,miRNAs involvement in the immune response in sepsis WP4329,0.6575682532202705,0.9103613777526821,0.3816296009361123,"['TAB2', 'NFKB1']",0.9893137093947314,0,0,2
302,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6575682532202705,0.9103613777526821,0.3816296009361123,"['AKT3', 'BRAF']",0.9893137093947314,0,0,2
303,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6575682532202705,0.9103613777526821,0.3816296009361123,"['MDH2', 'IDH2']",0.9893137093947314,0,0,2
304,EGF/EGFR signaling pathway WP437,0.6583876824867416,0.9233162207187298,0.38591048305163184,"['NDUFA13', 'RALBP1', 'STAT1', 'STXBP1', 'GAB1', 'PEBP1', 'CBLB', 'BRAF', 'NEDD8', 'ASAP1', 'FOS', 'AP2B1', 'CDC42', 'FOSB', 'GRB2', 'RAC1', 'MEF2D']",0.9893137093947314,0,0,17
305,Regulation of Actin Cytoskeleton WP51,0.6590165243052767,0.9180175058515024,0.38281942309450706,"['CYFIP2', 'PXN', 'BRK1', 'BRAF', 'ARPC5', 'ACTG1', 'CDC42', 'MRAS', 'TMSB4X', 'RAC1', 'MAPK6', 'FGF12', 'FGFR2', 'ARHGEF6']",0.9893137093947314,0,0,14
306,GABA receptor Signaling WP4159,0.6739264053246542,0.8738305084745762,0.3448435477810531,"['GABBR1', 'SLC32A1', 'AP2B1']",0.9893137093947314,0,0,3
307,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6853305903846345,0.8667313079077785,0.3274978425960808,"['NTRK2', 'ARC', 'HOMER1', 'AKT3', 'PRKAG1']",0.9893137093947314,0,0,5
308,Cytosine methylation WP3585,0.6859461726097764,0.9104119638826185,0.3431853614323486,['IDH2'],0.9893137093947314,0,0,1
309,EDA signaling in hair follicle development WP3930,0.6859461726097764,0.9104119638826185,0.3431853614323486,['LTB'],0.9893137093947314,0,0,1
310,Estrogen Receptor Pathway WP2881,0.6859461726097764,0.9104119638826185,0.3431853614323486,['ACOX1'],0.9893137093947314,0,0,1
311,Farnesoid X receptor pathway WP2879,0.6859461726097764,0.9104119638826185,0.3431853614323486,['SLC27A5'],0.9893137093947314,0,0,1
312,Thiamine metabolic pathways WP4297,0.6859461726097764,0.9104119638826185,0.3431853614323486,['TKT'],0.9893137093947314,0,0,1
313,Trans-sulfuration pathway WP2333,0.6859461726097764,0.9104119638826185,0.3431853614323486,['AHCY'],0.9893137093947314,0,0,1
314,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6870281842053225,0.8567442787391637,0.3216046352741634,"['H3F3B', 'H2AFY']",0.9893137093947314,0,0,2
315,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.6870281842053225,0.8567442787391637,0.3216046352741634,"['MAP1LC3A', 'ULK2']",0.9893137093947314,0,0,2
316,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.6870281842053225,0.8567442787391637,0.3216046352741634,"['B3GALNT1', 'SGPL1']",0.9893137093947314,0,0,2
317,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6870281842053225,0.8567442787391637,0.3216046352741634,"['EGR1', 'BRAF']",0.9893137093947314,0,0,2
318,Aryl Hydrocarbon Receptor Netpath WP2586,0.6892991427739104,0.8565823163635155,0.3187170906327681,"['HSP90AA1', 'CDKN1B', 'NCOA7', 'NFKB1']",0.9893137093947314,0,0,4
319,Autophagy WP4923,0.6973945564223636,0.8401564537157757,0.3027957047913086,"['MAP1LC3B', 'PRKAG1', 'WIPI2']",0.9893137093947314,0,0,3
320,PPAR signaling pathway WP3942,0.7034529927850778,0.8465089971587919,0.29776311517521964,"['ACADL', 'FABP5', 'ACOX1', 'PPARG', 'SLC27A5']",0.9893137093947314,0,0,5
321,Rett syndrome causing genes WP4312,0.7034529927850778,0.8465089971587919,0.29776311517521964,"['XAB2', 'STXBP1', 'IMPDH2', 'BRAF', 'SCN1A']",0.9893137093947314,0,0,5
322,Canonical and non-canonical Notch signaling WP3845,0.7143702021035349,0.8090846351715917,0.2721388215581293,"['MFAP1', 'DLL3']",0.9893137093947314,0,0,2
323,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7143702021035349,0.8090846351715917,0.2721388215581293,"['MDH2', 'SCO2']",0.9893137093947314,0,0,2
324,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7143702021035349,0.8090846351715917,0.2721388215581293,"['CALM1', 'NFKB1']",0.9893137093947314,0,0,2
325,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7164846431356624,0.8398850724826956,0.28001639403525264,"['MSH2', 'PXN', 'BAX', 'GRB2', 'RAC1', 'NFKB1']",0.9893137093947314,0,0,6
326,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7195573176878832,0.808976773383553,0.26624970159543876,"['STAR', 'PLCB1', 'NFKB1']",0.9893137093947314,0,0,3
327,Interferon type I signaling pathways WP585,0.7208352097943367,0.8272058823529411,0.2707814826270544,"['STAT1', 'RACK1', 'RAC1', 'EIF4B', 'IFNAR1']",0.9893137093947314,0,0,5
328,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.7238815289635417,0.8091923752194633,0.2614723367477472,['VHL'],0.9893137093947314,0,0,1
329,Dopamine metabolism WP2436,0.7238815289635417,0.8091923752194633,0.2614723367477472,['SOD1'],0.9893137093947314,0,0,1
330,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.7238815289635417,0.8091923752194633,0.2614723367477472,['PMVK'],0.9893137093947314,0,0,1
331,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7238815289635417,0.8091923752194633,0.2614723367477472,['TEAD1'],0.9893137093947314,0,0,1
332,Nanoparticle triggered regulated necrosis WP2513,0.7238815289635417,0.8091923752194633,0.2614723367477472,['TRADD'],0.9893137093947314,0,0,1
333,Osteopontin Signaling WP1434,0.7238815289635417,0.8091923752194633,0.2614723367477472,['NFKB1'],0.9893137093947314,0,0,1
334,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.7238815289635417,0.8091923752194633,0.2614723367477472,['NFKB1'],0.9893137093947314,0,0,1
335,TCA cycle in senescence WP5050,0.7238815289635417,0.8091923752194633,0.2614723367477472,['BRAF'],0.9893137093947314,0,0,1
336,NRF2 pathway WP2884,0.724653197822333,0.8560942244169364,0.27571549207374646,"['EGR1', 'HSP90AA1', 'HSP90AB1', 'SLC39A9', 'MGST3', 'SLC39A7', 'TXN', 'SQSTM1', 'CES2', 'CES4A']",0.9893137093947314,0,0,10
337,IL-3 signaling pathway WP286,0.7280901492000679,0.8088687896488914,0.25667866233657405,"['YWHAQ', 'YWHAB', 'GRB2', 'FOS']",0.9893137093947314,0,0,4
338,TGF-beta Signaling Pathway WP366,0.7361509674939579,0.8559307879881084,0.2621887723948166,"['TGFBR3', 'CDC42', 'KLF11', 'CCND1', 'SUMO1', 'WWP1', 'FOSB', 'GRB2', 'RAC1', 'FOS', 'RUNX2', 'SKP1']",0.9893137093947314,0,0,12
339,Kit receptor signaling pathway WP304,0.7374764425339105,0.8087606837606838,0.24628472023414447,"['STAT1', 'MITF', 'GRB2', 'FOS', 'MAPT']",0.9893137093947314,0,0,5
340,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7374764425339105,0.8087606837606838,0.24628472023414447,"['CAMK2D', 'STAT1', 'ISG15', 'PLCB1', 'NFKB1']",0.9893137093947314,0,0,5
341,Regulation of toll-like receptor signaling pathway WP1449,0.7378736556095707,0.8396127681841967,0.25522772885471573,"['OTUD5', 'STAT1', 'AKT3', 'TAB2', 'RAC1', 'FOS', 'SQSTM1', 'NFKB1', 'IFNAR1']",0.9893137093947314,0,0,9
342,Angiogenesis WP1539,0.7396760343010629,0.7664417961900799,0.23111514331753982,"['FLT1', 'FGFR2']",0.9893137093947314,0,0,2
343,Fatty Acid Biosynthesis WP357,0.7396760343010629,0.7664417961900799,0.23111514331753982,"['MECR', 'ECHS1']",0.9893137093947314,0,0,2
344,Glycerolipids and Glycerophospholipids WP4722,0.7396760343010629,0.7664417961900799,0.23111514331753982,"['DGAT2', 'CDIPT']",0.9893137093947314,0,0,2
345,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.7396760343010629,0.7664417961900799,0.23111514331753982,"['BMP2', 'SOX6']",0.9893137093947314,0,0,2
346,TLR4 Signaling and Tolerance WP3851,0.7396760343010629,0.7664417961900799,0.23111514331753982,"['TAB2', 'NFKB1']",0.9893137093947314,0,0,2
347,Alpha 6 Beta 4 signaling pathway WP244,0.7404355525011813,0.7800242130750605,0.2344102879801594,"['GAB1', 'GRB2', 'RAC1']",0.9893137093947314,0,0,3
348,Vitamin A and carotenoid metabolism WP716,0.7404355525011813,0.7800242130750605,0.2344102879801594,"['SULT1A1', 'ABCG8', 'RBP4']",0.9893137093947314,0,0,3
349,Histone Modifications WP2369,0.7460773424156074,0.7869463584556857,0.23051705528630187,"['SET', 'H3F3B', 'SMYD5', 'HIST1H4C']",0.9893137093947314,0,0,4
350,Wnt signaling WP428,0.750161971462894,0.8289201756652028,0.2382864781419486,"['WNT10B', 'SFRP1', 'CAMK2D', 'CCND2', 'CCND1', 'CSNK2A1', 'RAC1', 'PLCB1', 'NKD1']",0.9893137093947314,0,0,9
351,DNA IR-double strand breaks and cellular response via ATM WP3959,0.753379855861617,0.7911174503246114,0.22403316613719673,"['UPF1', 'MRE11', 'RNF8', 'RAD17', 'BAX']",0.9893137093947314,0,0,5
352,IL-1 signaling pathway WP195,0.753379855861617,0.7911174503246114,0.22403316613719673,"['TAB2', 'IL1RAP', 'SQSTM1', 'NFKB1', 'NFKBIB']",0.9893137093947314,0,0,5
353,Integrated breast cancer pathway WP1984,0.7568825051842213,0.8485692628387341,0.23636663350229312,"['MRE11', 'GADD45A', 'STAT1', 'TRADD', 'ODC1', 'BRAF', 'PHB', 'NFKB1', 'CDC42', 'CCND1', 'MSH2', 'BAX', 'RAC1', 'FAU']",0.9893137093947314,0,0,14
354,Disorders of Folate Metabolism and Transport WP4259,0.7572368244045842,0.728216704288939,0.20250193930496102,['MTHFD1'],0.9893137093947314,0,0,1
355,Glutathione metabolism WP100,0.7572368244045842,0.728216704288939,0.20250193930496102,['GPX4'],0.9893137093947314,0,0,1
356,Homologous recombination WP186,0.7572368244045842,0.728216704288939,0.20250193930496102,['MRE11'],0.9893137093947314,0,0,1
357,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.7572368244045842,0.728216704288939,0.20250193930496102,['NFKB1'],0.9893137093947314,0,0,1
358,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.7572368244045842,0.728216704288939,0.20250193930496102,['NFKB1'],0.9893137093947314,0,0,1
359,Neuroinflammation WP4919,0.7572368244045842,0.728216704288939,0.20250193930496102,['FOS'],0.9893137093947314,0,0,1
360,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.7572368244045842,0.728216704288939,0.20250193930496102,['ADAR'],0.9893137093947314,0,0,1
361,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7572368244045842,0.728216704288939,0.20250193930496102,['STAG1'],0.9893137093947314,0,0,1
362,Circadian rhythm related genes WP3594,0.757270294160838,0.8556027988884797,0.2378875495299214,"['EGR1', 'PRMT5', 'AHCY', 'HOMER1', 'KCND2', 'HEBP1', 'DBP', 'STAR', 'UBC', 'CRY2', 'CRY1', 'PPARG', 'ATF5', 'RPS27A', 'UBA52', 'SKP1']",0.9893137093947314,0,0,16
363,Fatty acid beta-oxidation WP143,0.7600583120772892,0.7530683810637054,0.20661193307437567,"['GCDH', 'ECHS1', 'ACADL']",0.9893137093947314,0,0,3
364,1q21.1 copy number variation syndrome WP4905,0.7630385452235179,0.7280632411067194,0.19690232350940973,"['AFDN', 'PRKAG1']",0.9893137093947314,0,0,2
365,7-oxo-C and 7beta-HC pathways WP5064,0.7630385452235179,0.7280632411067194,0.19690232350940973,"['DBP', 'SLC27A5']",0.9893137093947314,0,0,2
366,EPO Receptor Signaling WP581,0.7630385452235179,0.7280632411067194,0.19690232350940973,"['STAT1', 'GRB2']",0.9893137093947314,0,0,2
367,Nanoparticle triggered autophagic cell death WP2509,0.7630385452235179,0.7280632411067194,0.19690232350940973,"['MAP1LC3A', 'ULK2']",0.9893137093947314,0,0,2
368,Sphingolipid Metabolism (general overview) WP4725,0.7630385452235179,0.7280632411067194,0.19690232350940973,"['ASAH1', 'SGPL1']",0.9893137093947314,0,0,2
369,ATM Signaling Network in Development and Disease  WP3878,0.7631404948548681,0.7661777394305436,0.20710790276317298,"['MRE11', 'RNF8', 'NFKB1', 'HMGN1']",0.9893137093947314,0,0,4
370,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7650241577364774,0.8084356310985206,0.21653775932677435,"['MRAS', 'CCND1', 'AKT3', 'GAB1', 'BAX', 'BRAF', 'GRB2', 'FGFR2']",0.9893137093947314,0,0,8
371,Non-small cell lung cancer WP4255,0.7691706820652742,0.7958486693091733,0.2088644195567825,"['CDK6', 'CCND1', 'GADD45A', 'AKT3', 'BAX', 'BRAF', 'GRB2']",0.9893137093947314,0,0,7
372,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7749301531301223,0.7796507397526073,0.19879720016461208,"['WNT10B', 'SFRP1', 'CCND2', 'CCND1', 'CSNK2A1', 'NKD1']",0.9893137093947314,0,0,6
373,Nuclear Receptors Meta-Pathway WP2882,0.7773003995177652,0.8597729101035967,0.21660120394590682,"['NCOA1', 'EGR1', 'ABCG8', 'HSP90AA1', 'CDKN1B', 'HSP90AB1', 'MGST3', 'TXN', 'CES4A', 'SULT1A1', 'TGFBR3', 'PSMC5', 'CCND1', 'DNAJC7', 'NAV3', 'SLC39A9', 'ACOX1', 'BAX', 'SLC39A7', 'SQSTM1', 'CES2', 'SLC27A5']",0.9893137093947314,0,0,22
374,Parkinson's disease pathway WP2371,0.778461257622863,0.727909604519774,0.18229480928917455,"['SYT11', 'UBE2L6', 'UBE2G2']",0.9893137093947314,0,0,3
375,Type 2 papillary renal cell carcinoma WP4241,0.778461257622863,0.727909604519774,0.18229480928917455,"['ELOB', 'ELOC', 'VHL']",0.9893137093947314,0,0,3
376,Complement system WP2806,0.7792965559432931,0.7464741777913061,0.18614350139353608,"['RPS19', 'TXN', 'CALR', 'GNAI2']",0.9893137093947314,0,0,4
377,Alzheimer's disease WP2059,0.7816794764671131,0.7835438627058106,0.19299507988960363,"['ERN1', 'BACE1', 'ATP5MD', 'CALM3', 'MAPT', 'PLCB1', 'CALM1']",0.9893137093947314,0,0,7
378,Retinoblastoma gene in cancer WP2446,0.7816794764671131,0.7835438627058106,0.19299507988960363,"['CDKN1B', 'CDK6', 'CCND1', 'PRMT2', 'RBBP4', 'MCM4', 'MCM6']",0.9893137093947314,0,0,7
379,DNA Mismatch Repair WP531,0.7845578591917745,0.6933397865074884,0.16822846899129637,"['MSH2', 'POLE3']",0.9893137093947314,0,0,2
380,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7845578591917745,0.6933397865074884,0.16822846899129637,"['CBLB', 'NFKB1']",0.9893137093947314,0,0,2
381,Fluoropyrimidine Activity WP1601,0.7845578591917745,0.6933397865074884,0.16822846899129637,"['UMPS', 'CES2']",0.9893137093947314,0,0,2
382,Sphingolipid Metabolism (integrated pathway) WP4726,0.7845578591917745,0.6933397865074884,0.16822846899129637,"['ASAH1', 'SGPL1']",0.9893137093947314,0,0,2
383,ESC Pluripotency Pathways WP3931,0.7846026231793902,0.7984071677451469,0.1936759355966671,"['WNT10B', 'AKT3', 'GAB1', 'BRAF', 'GRB2', 'FOS', 'MAPK6', 'FGF12', 'FGFR2']",0.9893137093947314,0,0,9
384,Dopaminergic Neurogenesis WP2855,0.7865647495140814,0.6619638826185101,0.1589244436572851,['SOX2'],0.9893137093947314,0,0,1
385,FOXA2 pathway WP5066,0.7865647495140814,0.6619638826185101,0.1589244436572851,['SLC27A5'],0.9893137093947314,0,0,1
386,IL1 and megakaryocytes in obesity WP2865,0.7865647495140814,0.6619638826185101,0.1589244436572851,['NFKB1'],0.9893137093947314,0,0,1
387,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.7865647495140814,0.6619638826185101,0.1589244436572851,['NFKB1'],0.9893137093947314,0,0,1
388,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.7865647495140814,0.6619638826185101,0.1589244436572851,['DKK3'],0.9893137093947314,0,0,1
389,PI3K-Akt signaling pathway WP4172,0.7866823123782424,0.8610382075113603,0.2065895697815439,"['CDKN1B', 'FLT1', 'HSP90AB1', 'LPAR1', 'EFNA5', 'HSP90B1', 'GNG3', 'CCND2', 'CCND1', 'GNG4', 'AKT3', 'RAC1', 'EIF4B', 'NTRK2', 'HSP90AA1', 'NFKB1', 'CDK6', 'COL4A1', 'PPP2R2B', 'GNB1', 'GRB2', 'GNB5', 'FGF12', 'FGFR2', 'IFNAR1']",0.9893137093947314,0,0,25
390,Endoderm differentiation WP2853,0.7893927198585973,0.8081094715600958,0.1911108903163834,"['SOX2', 'SFRP1', 'STAT1', 'SESN1', 'TCEAL2', 'CTR9', 'LEO1', 'CEBPZ', 'RTF1', 'ASCC3', 'TRERF1']",0.9893137093947314,0,0,11
391,Genes related to primary cilium development (based on CRISPR) WP4536,0.7919542779265071,0.7992744634831986,0.18643206241294755,"['DYNC2H1', 'KIF3B', 'C2CD3', 'DYNLT1', 'ARL6', 'ARL3', 'WDR19', 'BBS9', 'TXNDC15', 'BBS4']",0.9893137093947314,0,0,10
392,DNA IR-damage and cellular response via ATR WP4016,0.7936765265957597,0.7716119290298226,0.17830354287193959,"['UPF1', 'MRE11', 'MSH2', 'XRCC5', 'USP1', 'RAD17', 'ATRIP']",0.9893137093947314,0,0,7
393,IL-4 signaling pathway WP395,0.7945662875913405,0.7277557942340305,0.16735389527047884,"['STAT1', 'GRB2', 'FOS', 'NFKB1']",0.9893137093947314,0,0,4
394,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.7945662875913405,0.7277557942340305,0.16735389527047884,"['GRB2', 'FOS', 'CALM1', 'NFKB1']",0.9893137093947314,0,0,4
395,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.7967454086512721,0.7425085418782897,0.1687128564474209,"['CDKN1B', 'ERBB4', 'TMSB4X', 'GRB2', 'SOD1']",0.9893137093947314,0,0,5
396,Integrin-mediated Cell Adhesion WP185,0.7995835704184131,0.7759169027384325,0.17354485179794668,"['CDC42', 'AKT3', 'PXN', 'BRAF', 'GRB2', 'ITGAE', 'RAC1', 'MAPK6']",0.9893137093947314,0,0,8
397,Vitamin B12 metabolism WP1533,0.8043382569300312,0.6617730095990966,0.1440913981855705,"['NFKB1', 'SOD1']",0.9893137093947314,0,0,2
398,Pathways in clear cell renal cell carcinoma WP4018,0.8051683489172162,0.7600361724784909,0.1647027984140678,"['FLT1', 'PLOD2', 'VHL', 'ALDOA', 'SQSTM1', 'PFKM', 'KCNJ2']",0.9893137093947314,0,0,7
399,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8051683489172162,0.7600361724784909,0.1647027984140678,"['THRA', 'TBC1D4', 'AKT3', 'PPARG', 'GRB2', 'PLCB1', 'MGLL']",0.9893137093947314,0,0,7
400,Energy Metabolism WP1541,0.8089736207201417,0.7099505025575976,0.1505016755917463,"['NCOA1', 'PRKAG1', 'PPARG', 'MEF2D']",0.9893137093947314,0,0,4
401,AGE/RAGE pathway WP2324,0.809793837615056,0.7276018099547511,0.15350621762932437,"['CDC42', 'STAT1', 'RAC1', 'NFKB1', 'SOD1']",0.9893137093947314,0,0,5
402,Matrix Metalloproteinases WP129,0.8123513331578267,0.6067531978931527,0.12609687915440168,['MMP16'],0.9893137093947314,0,0,1
403,Omega-3/Omega-6 FA synthesis WP4723,0.8123513331578267,0.6067531978931527,0.12609687915440168,['ACOX1'],0.9893137093947314,0,0,1
404,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8124734494642418,0.7398348248971253,0.15364300949098422,"['CDK8', 'RBP4', 'SEC24B', 'PRKAG1', 'PPARG', 'KPNB1']",0.9893137093947314,0,0,6
405,Hematopoietic Stem Cell Differentiation WP2849,0.8224857145902238,0.6329511698131736,0.12369395370270841,"['FOSB', 'FOS']",0.9893137093947314,0,0,2
406,Signal transduction through IL1R WP4496,0.8224857145902238,0.6329511698131736,0.12369395370270841,"['IL1RAP', 'NFKB1']",0.9893137093947314,0,0,2
407,T-cell receptor (TCR) signaling pathway WP69,0.8238370395556938,0.7274476513865309,0.14096665080985568,"['CDC42', 'CD83', 'CBLB', 'GRB2', 'FOS', 'NFKB1']",0.9893137093947314,0,0,6
408,G13 Signaling Pathway WP524,0.8267787002038907,0.6615819209039548,0.12584493090202692,"['CDC42', 'RAC1', 'CALM1']",0.9893137093947314,0,0,3
409,Hedgehog Signaling Pathway WP4249,0.8267787002038907,0.6615819209039548,0.12584493090202692,"['CCND2', 'CCND1', 'GLI3']",0.9893137093947314,0,0,3
410,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8267787002038907,0.6615819209039548,0.12584493090202692,"['CAMK2D', 'CALM1', 'NFKB1']",0.9893137093947314,0,0,3
411,Acute viral myocarditis WP4298,0.8338785649581787,0.6995083536373129,0.12707792879140092,"['CCND1', 'STAT1', 'BAX', 'EIF4G2', 'EIF4G1']",0.9893137093947314,0,0,5
412,ERK Pathway in Huntington's Disease WP3853,0.8350239786987965,0.5600364646640041,0.10097168341254621,['NTRK2'],0.9893137093947314,0,0,1
413,Fatty acid transporters WP5061,0.8350239786987965,0.5600364646640041,0.10097168341254621,['FABP5'],0.9893137093947314,0,0,1
414,Kennedy pathway from sphingolipids WP3933,0.8350239786987965,0.5600364646640041,0.10097168341254621,['SGPL1'],0.9893137093947314,0,0,1
415,Mammalian disorder of sexual development WP4842,0.8350239786987965,0.5600364646640041,0.10097168341254621,['FGFR2'],0.9893137093947314,0,0,1
416,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8350239786987965,0.5600364646640041,0.10097168341254621,['RUNX2'],0.9893137093947314,0,0,1
417,Lipid Metabolism Pathway WP3965,0.8391059758405458,0.6065311500094108,0.10639664406844349,"['AKT3', 'PRKAG1']",0.9893137093947314,0,0,2
418,Oxysterols derived from cholesterol WP4545,0.8391059758405458,0.6065311500094108,0.10639664406844349,"['DBP', 'SLC27A5']",0.9893137093947314,0,0,2
419,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8407455856652611,0.6420737786640079,0.11137808492335699,"['YWHAQ', 'TEAD1', 'ACTG1']",0.9893137093947314,0,0,3
420,Wnt Signaling Pathway WP363,0.8472960848519892,0.6613906161673262,0.10959578266327259,"['CDK6', 'CCND1', 'PPARG', 'RAC1']",0.9893137093947314,0,0,4
421,Adipogenesis WP236,0.8512002733385132,0.7352098142627838,0.1184480645885006,"['BSCL2', 'NCOA1', 'WNT10B', 'BMP2', 'GADD45A', 'STAT1', 'DDIT3', 'PPARG', 'MEF2D']",0.9893137093947314,0,0,9
422,Allograft Rejection WP2328,0.8537266825474005,0.623680387409201,0.09863142361982044,"['STAT1', 'HLA-A', 'HLA-F']",0.9893137093947314,0,0,3
423,Interleukin-11 Signaling Pathway WP2332,0.8537266825474005,0.623680387409201,0.09863142361982044,"['STAT1', 'GRB2', 'RUNX2']",0.9893137093947314,0,0,3
424,Cardiac Progenitor Differentiation WP2406,0.8543030644519493,0.5822247317899492,0.09168250450390521,"['SOX2', 'MESP1']",0.9893137093947314,0,0,2
425,Cholesterol Biosynthesis Pathway WP197,0.8549585318773049,0.5199935504675911,0.0814841915572948,['PMVK'],0.9893137093947314,0,0,1
426,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8549585318773049,0.5199935504675911,0.0814841915572948,['ACOX1'],0.9893137093947314,0,0,1
427,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8549585318773049,0.5199935504675911,0.0814841915572948,['FGFR2'],0.9893137093947314,0,0,1
428,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.8549585318773049,0.5199935504675911,0.0814841915572948,['PXN'],0.9893137093947314,0,0,1
429,PPAR-alpha pathway WP2878,0.8549585318773049,0.5199935504675911,0.0814841915572948,['CCND1'],0.9893137093947314,0,0,1
430,Hippo-Merlin Signaling Dysregulation WP4541,0.8569926314269828,0.7181058300982758,0.11082237055076914,"['DDB1', 'NTRK2', 'FLT1', 'CCND1', 'ITGAE', 'TEAD1', 'FGFR2', 'CDH18']",0.9893137093947314,0,0,8
431,Wnt signaling pathway and pluripotency WP399,0.8640259780598519,0.6972416574877054,0.10190357190383956,"['SOX2', 'WNT10B', 'CCND2', 'CCND1', 'PPP2R2B', 'PRKD1', 'NKD1']",0.9893137093947314,0,0,7
432,Common Pathways Underlying Drug Addiction WP2636,0.8657733395536196,0.6063088512241055,0.08738859058764191,"['GRM5', 'CALM1', 'ACTG1']",0.9893137093947314,0,0,3
433,Peptide GPCRs WP24,0.8681781586177242,0.5597880380489076,0.07913070418264959,"['OPRD1', 'NMBR']",0.9893137093947314,0,0,2
434,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8681781586177242,0.5597880380489076,0.07913070418264959,"['BAX', 'BRAF']",0.9893137093947314,0,0,2
435,Zinc homeostasis WP3529,0.8681781586177242,0.5597880380489076,0.07913070418264959,"['SLC39A9', 'SLC39A7']",0.9893137093947314,0,0,2
436,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8724854974183098,0.48528969149736645,0.06619800135220144,['RBBP4'],0.9893137093947314,0,0,1
437,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.8724854974183098,0.48528969149736645,0.06619800135220144,['ACADL'],0.9893137093947314,0,0,1
438,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8724854974183098,0.48528969149736645,0.06619800135220144,['BMP2'],0.9893137093947314,0,0,1
439,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.8724854974183098,0.48528969149736645,0.06619800135220144,['NFKB1'],0.9893137093947314,0,0,1
440,Transcription factor regulation in adipogenesis WP3599,0.8724854974183098,0.48528969149736645,0.06619800135220144,['PPARG'],0.9893137093947314,0,0,1
441,Joubert Syndrome WP4656,0.8726390787708893,0.6712289408384485,0.09144369004011398,"['MRE11', 'CSPP1', 'ARL3', 'BBS9', 'CEP41', 'BBS4']",0.9893137093947314,0,0,6
442,One-carbon metabolism and related pathways WP3940,0.8769368145387748,0.589876316994961,0.0774627564303531,"['GPX4', 'CDO1', 'SOD1']",0.9893137093947314,0,0,3
443,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.8808287623868309,0.5390133216220173,0.06839649957030229,"['SUPT5H', 'NFKB1']",0.9893137093947314,0,0,2
444,Nuclear receptors WP170,0.8808287623868309,0.5390133216220173,0.06839649957030229,"['THRA', 'PPARG']",0.9893137093947314,0,0,2
445,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8809081156553547,0.6610073571024335,0.08381702448598527,"['CAMK2D', 'RAC1', 'CALM1', 'PRKG1', 'NFKB1', 'FGFR2']",0.9893137093947314,0,0,6
446,Apoptosis Modulation by HSP70 WP384,0.8878955057312707,0.4549238148984199,0.05409099506998212,['NFKB1'],0.9893137093947314,0,0,1
447,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8878955057312707,0.4549238148984199,0.05409099506998212,['PPARG'],0.9893137093947314,0,0,1
448,MAPK Signaling Pathway WP382,0.8881425634534412,0.7722930902647134,0.0916117266803131,"['NTRK2', 'DUSP3', 'GADD45A', 'PLA2G4C', 'BRAF', 'TRAF2', 'FOS', 'NFKB1', 'CDC42', 'MRAS', 'CACNB4', 'DDIT3', 'AKT3', 'RAPGEF2', 'GRB2', 'TAB2', 'RAC1', 'MAPT', 'FGF12', 'FGFR2']",0.9893137093947314,0,0,20
449,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8899475763894864,0.7789221490158934,0.09081665274170028,"['RAB2A', 'HSP90AA1', 'CDKN1B', 'FLT1', 'HSP90AB1', 'LPAR1', 'ITGAE', 'EFNA5', 'HSP90B1', 'GNG3', 'RAB14', 'PIK3IP1', 'COL4A1', 'GNG4', 'PPP2R2B', 'AKT3', 'GNB1', 'GRB2', 'FGF12', 'FGFR2', 'EIF4B', 'IFNAR1']",0.9893137093947314,0,0,22
450,Neural Crest Differentiation WP2064,0.8915156333218411,0.6268528631611796,0.07198295971020618,"['HDAC11', 'MITF', 'NFKB1', 'FGFR2', 'DLL3']",0.9893137093947314,0,0,5
451,Base Excision Repair WP4752,0.8923481179028265,0.5197225135113334,0.05919585160985081,"['NEIL2', 'POLE3']",0.9893137093947314,0,0,2
452,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9014441215675738,0.4281303943699376,0.04442162041665125,['ACOX1'],0.9893137093947314,0,0,1
453,Purinergic signaling WP4900,0.9014441215675738,0.4281303943699376,0.04442162041665125,['GNAI2'],0.9893137093947314,0,0,1
454,Vitamin D in inflammatory diseases WP4482,0.9014441215675738,0.4281303943699376,0.04442162041665125,['NFKB1'],0.9893137093947314,0,0,1
455,MAPK Cascade WP422,0.9028248133541174,0.501762105960007,0.05129350913038472,"['BRAF', 'GRB2']",0.9893137093947314,0,0,2
456,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.9028248133541174,0.501762105960007,0.05129350913038472,"['BAX', 'HIF1AN']",0.9893137093947314,0,0,2
457,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9056299593859407,0.5455084745762712,0.054073249180105296,"['BANF1', 'GRB2', 'EMD']",0.9893137093947314,0,0,3
458,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9123425470941542,0.4849990589121024,0.044493697043586626,"['NTRK2', 'AP2B1']",0.9893137093947314,0,0,2
459,Prostaglandin Synthesis and Regulation WP98,0.9123425470941542,0.4849990589121024,0.044493697043586626,"['MITF', 'PPARG']",0.9893137093947314,0,0,2
460,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.913356072332713,0.40431402056684224,0.03664276615094061,['PRKAG1'],0.9893137093947314,0,0,1
461,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.913356072332713,0.40431402056684224,0.03664276615094061,['BAX'],0.9893137093947314,0,0,1
462,Kallmann's Syndrome WP5074,0.913356072332713,0.40431402056684224,0.03664276615094061,['GRB2'],0.9893137093947314,0,0,1
463,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.913356072332713,0.40431402056684224,0.03664276615094061,['FOS'],0.9893137093947314,0,0,1
464,Statin inhibition of cholesterol production WP430,0.913356072332713,0.40431402056684224,0.03664276615094061,['ABCG8'],0.9893137093947314,0,0,1
465,Insulin Signaling WP481,0.9183419228702748,0.6991877104377104,0.05956064960986515,"['EGR1', 'XBP1', 'ARF1', 'STXBP4', 'STXBP1', 'GAB1', 'CBLB', 'FOS', 'TBC1D4', 'GRB2', 'RAC1', 'MAPK6', 'PFKM']",0.9893137093947314,0,0,13
466,Ciliopathies WP4803,0.9193906433943775,0.705814541090266,0.059319599060194614,"['DYNC2H1', 'C2CD3', 'ARL6', 'ARL3', 'WDR19', 'LCA5', 'CCDC28B', 'GLI3', 'TTLL5', 'RSPH1', 'CSPP1', 'BBS9', 'CEP41', 'BBS4']",0.9893137093947314,0,0,14
467,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.920980016885519,0.4693174987705142,0.038632780459950264,"['STAT1', 'NFKB1']",0.9893137093947314,0,0,2
468,Monoamine Transport WP727,0.9238289678186311,0.3830046334798622,0.030344815285583155,['AMPH'],0.9893137093947314,0,0,1
469,Urea cycle and associated pathways WP4595,0.9238289678186311,0.3830046334798622,0.030344815285583155,['MDH2'],0.9893137093947314,0,0,1
470,Metapathway biotransformation Phase I and II WP702,0.9274847388801352,0.6317034117502155,0.04755396239298906,"['SULT1A1', 'AKR7A2', 'GPX4', 'GSTO1', 'MGST3', 'HNMT', 'NAT14', 'SULT4A1']",0.9893137093947314,0,0,8
471,ATM Signaling Pathway WP2516,0.9288109068051682,0.4546160361377753,0.03357344235250423,"['MRE11', 'GADD45A']",0.9893137093947314,0,0,2
472,Bladder cancer WP2828,0.9288109068051682,0.4546160361377753,0.03357344235250423,"['CCND1', 'BRAF']",0.9893137093947314,0,0,2
473,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9288109068051682,0.4546160361377753,0.03357344235250423,"['DDIT3', 'FOS']",0.9893137093947314,0,0,2
474,Vitamin D-sensitive calcium signaling in depression WP4698,0.9288109068051682,0.4546160361377753,0.03357344235250423,"['GRM5', 'GPX4']",0.9893137093947314,0,0,2
475,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9314343930829453,0.5384921382660218,0.038248839663129204,"['RYR2', 'CACNB4', 'EMD', 'ACTG1']",0.9893137093947314,0,0,4
476,Gastric Cancer Network 1 WP2361,0.9330365699444416,0.36382618510158016,0.0252171140827902,['MCM4'],0.9893137093947314,0,0,1
477,Heart Development WP1591,0.9330365699444416,0.36382618510158016,0.0252171140827902,['BMP2'],0.9893137093947314,0,0,1
478,Microglia Pathogen Phagocytosis Pathway WP3937,0.9330365699444416,0.36382618510158016,0.0252171140827902,['RAC1'],0.9893137093947314,0,0,1
479,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9330365699444416,0.36382618510158016,0.0252171140827902,['PLCB1'],0.9893137093947314,0,0,1
480,Toll-like Receptor Signaling related to MyD88 WP3858,0.9330365699444416,0.36382618510158016,0.0252171140827902,['NFKB1'],0.9893137093947314,0,0,1
481,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9359039503084234,0.44080557124035386,0.029200029975678617,"['MAP1LC3A', 'NFKB1']",0.9893137093947314,0,0,2
482,Fas ligand pathway and stress induction of heat shock proteins WP314,0.9359039503084234,0.44080557124035386,0.029200029975678617,"['CFLAR', 'ACTG1']",0.9893137093947314,0,0,2
483,Pathways affected in adenoid cystic carcinoma WP3651,0.9369633396591073,0.5286602600339174,0.034421663078582944,"['MAGI1', 'MAGI2', 'ARID5B', 'DTX4']",0.9893137093947314,0,0,4
484,Glucocorticoid Receptor Pathway WP2880,0.9402657738659731,0.4847080979284369,0.02985448314162675,"['TGFBR3', 'HSP90AA1', 'NAV3']",0.9893137093947314,0,0,3
485,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.9411316701618112,0.34647425561646783,0.021021363439959195,['CCND1'],0.9893137093947314,0,0,1
486,Notch Signaling WP268,0.942323050890133,0.42780748663101603,0.02541481142237938,"['DTX4', 'DLL3']",0.9893137093947314,0,0,2
487,Thermogenesis WP4321,0.9464838054875095,0.5844040041134586,0.03214304912783352,"['PRKAG1', 'GRB2', 'PPARG', 'ARID1B', 'PRKG1', 'MGLL', 'ACTG1']",0.9893137093947314,0,0,7
488,MTHFR deficiency WP4288,0.9482486184850754,0.3306997742663657,0.017572908250556407,['HNMT'],0.9893137093947314,0,0,1
489,Monoamine GPCRs WP58,0.9545055484231725,0.3162969869467072,0.014727364297172299,['HTR5A'],0.9893137093947314,0,0,1
490,"GPCRs, Class A Rhodopsin-like WP455",0.959769172304875,0.5379697750948458,0.022090367184615982,"['OPRD1', 'GPR173', 'GPR22', 'PRLHR', 'NMBR', 'HTR5A']",0.9893137093947314,0,0,6
491,Wnt signaling in kidney disease WP4150,0.9600063333482592,0.30309443190368696,0.012370919658853948,['WNT10B'],0.9893137093947314,0,0,1
492,Ethanol effects on histone modifications WP3996,0.9648423069885449,0.29094808126410837,0.010413207399177764,['AHCY'],0.9893137093947314,0,0,1
493,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9648423069885449,0.29094808126410837,0.010413207399177764,['TGFBR3'],0.9893137093947314,0,0,1
494,Glycerophospholipid Biosynthetic Pathway WP2533,0.9648423069885449,0.29094808126410837,0.010413207399177764,['CDIPT'],0.9893137093947314,0,0,1
495,MECP2 and Associated Rett Syndrome WP3584,0.9685265497306065,0.46124166644234477,0.014750224027981594,"['PRPF38A', 'SST', 'TAP1', 'YBX1']",0.9893137093947314,0,0,4
496,Neovascularisation processes WP4331,0.9690937765750448,0.2797360652891127,0.008782004695721988,['NFKB1'],0.9893137093947314,0,0,1
497,Oxidation by Cytochrome P450 WP43,0.9690937765750448,0.2797360652891127,0.008782004695721988,['CYB5R3'],0.9893137093947314,0,0,1
498,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9697015492114711,0.36346696781479393,0.011182764956344807,"['PMVK', 'TM7SF2']",0.9893137093947314,0,0,2
499,"GPCRs, Other WP117",0.9697015492114711,0.36346696781479393,0.011182764956344807,"['CELSR2', 'ADGRL3']",0.9893137093947314,0,0,2
500,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9722561755020557,0.547672243305361,0.015409281155872088,"['WNT10B', 'FMNL2', 'RBBP4', 'COL4A1', 'AKT3', 'GRB2', 'MEF2D', 'DLL3']",0.9893137093947314,0,0,8
501,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9728269640199848,0.35457437578328355,0.00976818728028377,"['MAP1LC3A', 'WIPI2']",0.9893137093947314,0,0,2
502,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9728313531666792,0.26935456901596855,0.007419247288837717,['CDKN1B'],0.9893137093947314,0,0,1
503,Phosphoinositides metabolism WP4971,0.9781699623874656,0.33803001851535724,0.007460943934246465,"['PLCB1', 'SBF2']",0.9893137093947314,0,0,2
504,Lung fibrosis WP3624,0.9790056711548822,0.25073947225033083,0.005320150922762779,['ATP11A'],0.9893137093947314,0,0,1
505,AMP-activated protein kinase (AMPK) signaling WP1403,0.9792829016883982,0.38916464891041164,0.00814704834170351,"['PRKAG1', 'PLCB1', 'CAMKK2']",0.9893137093947314,0,0,3
506,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9792829016883982,0.38916464891041164,0.00814704834170351,"['CDKN1B', 'YWHAQ', 'FAT1']",0.9893137093947314,0,0,3
507,Mesodermal commitment pathway WP2857,0.9795646584540407,0.507916194790487,0.010486961969037508,"['SOX2', 'CCND1', 'SESN1', 'ARID5B', 'ASCC3', 'TRERF1', 'TEAD1']",0.9893137093947314,0,0,7
508,Regulatory circuits of the STAT3 signaling pathway WP4538,0.98124071497976,0.3823074635741897,0.007239937028776854,"['PTPRD', 'MAPK6', 'IFNAR1']",0.9893137093947314,0,0,3
509,Focal Adhesion WP306,0.9815997623429207,0.575967146902535,0.010696647418209694,"['CDC42', 'CCND2', 'FLT1', 'CCND1', 'COL4A1', 'AKT3', 'PXN', 'BRAF', 'GRB2', 'RAC1', 'MYL12B', 'ACTG1']",0.9893137093947314,0,0,12
510,Phosphodiesterases in neuronal function WP4222,0.9843243229175019,0.315910932168021,0.0049913421111062485,"['PDE10A', 'PDE4D']",0.9901144659934872,0,0,2
511,Netrin-UNC5B signaling pathway WP4747,0.988981221046624,0.21378303014207942,0.00236870215484359,['RAC1'],0.9928519890350649,0,0,1
512,Male infertility WP4673,0.9973178630953405,0.32583634504354014,0.0008751117960665403,"['NANOS1', 'MTHFD1', 'UBE2B', 'XRCC5']",0.9990271186238829,0,0,4
513,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9990271186238829,0.32325670652876537,0.00031464350972167554,"['ABCG8', 'THRA', 'PRKAG1', 'CBLB', 'MAPK6']",0.9990271186238829,0,0,5
